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Abstract
Despite defibrillation as the only effective treatment for sudden cardiac arrest (SCA), less
than 15% of homes and public facilities have access to an automated external defibrillator
(AED). In the United States, ineffective response to SCA cases occurring each year
classifies it as a business problem for medical device manufacturing leaders, emergency
responders, and bystanders. The purpose of this multicase study was to explore the
marketing strategies AED manufacturing leaders use to expand their consumer customer
base. Data were collected via in-depth interviews from a purposive sample of participants
from 2 U.S. AED manufacturers on the east coast, 2 AED distributors, and 2 healthcare
corporations in Texas, as well as a review of company materials. The framework for this
study was product life cycle theory. Initial findings for expanding the U.S. AED market
indicated that the market was not led by its manufacturers but by its distributors. This
finding became an important theme noted from AED manufacturers in considering the
consumer segment, an aftermarket from commercial marketing strategies. A common
concern for the security of strategic marketing was evident across the AED manufacturer
participants with reluctance to discuss business models and marketing plans. A congruent
theme was the curtailment of open discussions regarding AED marketing strategies
because of security and confidentiality risk. Also limited number of approved AED
manufacturers by the Federal Drug Administration minimizes AED access. Residual
outcomes include improving the quality of life for the aging population while reducing
the loss of the lives and costs of healthcare. Social implications include preventing
sudden cardiac death by providing more accessibility of AEDs to baby boomers.
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Section 1: Foundation of the Study
The rising awareness of sudden cardiac arrest (SCA) and defibrillation in the
United States are contributing to the growth of the defibrillator market. Sales of
automated external defibrillators (AED) are increasing as part of patient monitoring
service programs (Frost & Sullivan, 2012). Other contributors to the increase of
awareness include more distribution of information and knowledge ascertained by the
public of their effectiveness during critical minutes of resuscitation (AHA, 2014). The
study includes exploring outcomes of public awareness and distribution of information
regarding SCA.
In February of 2015, market researchers from Frost and Sullivan, Vision Gain,
and Transparency, reported on the North American AED market. These market
researchers estimated the market to grow at a compound annual growth rate (CAGR) of
6.8% from 2014 to 2019 in the prevention of SCD. Furthermore, the same researchers
concluded the United States continued to have a larger share of the AED market with
about 85% in 2013 (Frost & Sullivan, 2012). In North America, the top seven
manufacturers in the external defibrillator market control approximately 89.9% of the
market. Of the seven manufacturers, three are U.S.-based companies controlling 85% of
the market (Frost & Sullivan, 2012). The three manufacturers are Pseudo AED U.S.,
Pseudo2 AED U.S., and Pseudo3 AED U.S.
The rising incidences of cardiovascular diseases (CVD) and SCA have various
root causes. These causes include obesity, smoking, lack of exercise, and other heart
diseases contribute to the increasing awareness of SCA and the life-saving potential of
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AEDs (Heidenreich, Trogdon, & Khavjou, 2011). Businesses and individuals are
recognizing the value of acquiring an AED and the importance of its accessibility through
personal experience and published information from such sources as the American Heart
Association (AHA).
Governance and federal compliances are a component of AED manufacturing and
its public access. The AHA as well as state legislation such as the District of Columbia,
have public access defibrillation statutes and regulations in effect in 51 U.S. Jurisdictions
(Gilchrist et al., 2012). They advocate the installation of AEDs for public access, what is
referred to as a public access defibrillator (PAD). Government campaigns, media
coverage, Internet articles, and word of mouth, are some of the driving factors for market
growth in small, medium, and large businesses as well as consumer markets.
The AHA (2014) determined that the survival rate of those treated with an AED,
coupled with cardiopulmonary resuscitation (CPR), nearly doubles those treated with
CPR alone. Timely application and general understanding of the AED by the user or
bystander will yield a higher chance of survival (Yeung, Okamoto, Soar, & Perkins,
2011). Therefore, accessibility to an AED and bystander training during SCA incidents
increases the chance of a victim’s survival.
Growing direct sales channels and distributor network expansion by AED
manufacturers are posting gains in the emerging U.S. commercial market segment.
The top three AED manufacturers sold more AEDs to the commercial and consumer
sector between 2013 and 2014 than any other year prior. Sales to corporate workplaces
and public facilities have surged based on the growing demand and account for more than

3
40% of leading manufacturers’ domestic AED revenue (Frost & Sullivan, 2012). U.S.
medical device manufacturers’ AED sales grew at a rate of approximately 70%
(Heidenreich, Trogdon, & Khavjou, 2011). This percent is more than twice the rate of
growth of the worldwide AED market. Market revenue for 2010 was $547.4 million and
reaching $803.9 million in 2016 (Frost & Sullivan, 2011). While this is a substantial
ground trend, AED sales are targeted to the business and public facilities markets.
Defibrillation is the only treatment for SCA victims during life-threatening
cardiac arrhythmias, ventricular fibrillation, and pulseless ventricular tachycardia (Go et
al., 2014). Automated external defibrillators provide an electrical shock terminating the
arrhythmia and restoring the normal rhythm in the heart. Defibrillator devices are useful
and the only means of preventing deaths during SCA (Go et al., 2014) for patients with
unknown heart conditions. The number of SCA incidents continues to increase year over
year.
The baby boomer population is aging in the United States alongside the rising
cases of hypertension among adults 65 years and older. As more Americans continue
smoking cigarettes, ingesting a poor diet, and curtailing their physical exercise, SCA
numbers will trend upward (AHA, 2013). Because of these contributors and
cardiovascular diseases, they become the major drivers of AED market growth. If
medical device manufacturing and distribution marketing leaders design and execute
marketing strategies and plans timely and effectively, they may position themselves for
future growth in the customer base.
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There are considerable costs associated with CVD. The direct and indirect cost of
CVD and strokes in the United States for 2014 is $315 billion (Go et al., 2014). Coronary
heart disease (CHD), in the United States alone, is costing $108 billion each year
(Heidenreich et al., 2011). Coronary heart disease took one of every six lives in 2010. Per
the AHA (2013), an estimated 620,000 Americans have a new coronary attack annually.
A coronary attack is a first hospitalized myocardial infarction with 295,000 developing a
recurring attack annually. The AHA (2013) estimated an additional 150,000 silent first
myocardial infarctions occur each year. Every 34 seconds one American has a coronary
event (Go et al., 2014). Every minute seven seconds one American dies of a myocardial
infarction and nearly 400,000 out-of-hospital sudden cardiac arrests occur annually
(AHA, 2014). Many deaths from CVD impact both the direct and indirect costs of caring
for stroke and post SCA victims.
The U.S. Department of Health & Human Services (HHS) has a very honorable
mission. Its priorities are based on enhancing and protecting the health and well-being of
all Americans. Statistics from both the AHA and the U.S. Department of Health and
Human Services confirm more than 900 deaths to sudden cardiac arrest each day
(USDHHS, 2013). Public Access Defibrillation (PAD) programs, AED Programs for
businesses, and other community-based chain-of-survival initiatives (Fothergill et al.,
2013) assist SCA victims. Given the growth continuum in sudden cardiac death (SCD),
there is a need for more aggressive marketing campaigns by medical device manufacturer
marketing leaders to capture the commercial and consumer AED market. The goal of this
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study was to explore strategic opportunities for medical device manufacturing company
leaders to expand their AED customer base.
Background of the Problem
Having access to an AED anywhere is as important as the ability to apply it to
prevent sudden cardiac death (SCD). The United States is the largest market for
defibrillator devices and expecting to retain its top position through 2019.
Notwithstanding its market position, approximately 350,000 Americans lives are lost
annually to sudden cardiac arrest with 88% of all SCAs in the United States occurring at
home and public facilities (AHA, 2013). Cardio Vascular Disease and stroke in the
United States account for more than 930,000 deaths per year. The estimated cost is $315
billion (Go et al., 2014). The lack of AED programs and accessibility to public facilities,
workplace, and homes is contributing to a $108 billion expense each year (Heidenreich et
al., 2011). As a result of this large expense on SCA, medical device manufacturers’ AED
sales grew at a rate of approximately 70% (Heidenreich et al., 2011). This rate is more
than twice the growth of the worldwide AED market. Despite this rate of growth, less
than 34% of United States has public access to an AED, and less than 15% of private
facilities have an AED (AHA, 2012). The AHA has previously addressed potential
preventive initiatives for out-of-hospital SCA by way of CPR and defibrillation; Public
Access Defibrillation (PAD); and bystander training.
In this study, I explored whether device manufacturing and distribution marketing
leaders are maximizing their strategies on the AED customer base growth or leaving
expansion opportunities in the U.S. home and public settings untapped. In addition, this
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research includes consumer AED market opportunities, which are based on SCA statistics
that indicate growth. In this study, I addressed research questions to the problem and
discuss the business and social change implications of this research.
Problem Statement
Defibrillation is the only effective treatment for sudden cardiac arrest, yet less
than 15% of public facilities and homes have an AED (Go et al., 2014). Medical device
manufacturing and distribution marketing leaders are leaving an 85% potential market in
the consumer segment unequipped (AHA, 2012). The general business problem is that
some medical device manufacturing and distribution marketing leaders are not
maximizing their sales potential in the U.S. consumer AED markets. The specific
business problem is that some medical device manufacturing leaders have limited
marketing strategies to expand their AED consumer base in the United States.
Purpose Statement
The purpose of this multicase study was to explore the marketing strategies
medical device manufacturing company leaders use to expand their consumer customer
base. The research method is qualitative with a multicase study as the research design.
The population included medical device manufacturing marketing professionals from the
top 3 U.S. companies, its distributors, and healthcare professionals. During the research
and interviews, it was determined that while they were aware that the consumer base was
expanding, their marketing strategies were not focused on this space.
A qualitative multicase study is a valuable method for research to develop theory,
evaluate programs, and develop interventions (Baxter & Jack, 2008). The subset of the
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sample was the company’s consumer goods division responsible for the U.S. market.
Expected outcomes of the research include convincing corporate leaders of their potential
and financial gain. The sample may also contribute to business growth in the medical
device industry and assist in reducing the $100 billion in annual expense for U.S.
consumers (Heidenreich et al., 2011). As part of social change, the use of AEDs may
prevent the loss of the lives of more than 350,000 SCA victims dying annually of which
88% are occurring at home and within public settings (AHA, 2013).
Nature of the Study
For this study, I used a qualitative, multicase study. The method identifies
business issues across the population and not from a hypothesis (see Yin, 2013). As a
form of inductive research, the qualitative approach was appropriate. This multicase
includes medical device manufacturing company leaders and marketing professionals
from various companies and healthcare professionals. The case study design assisted in
my understanding of what marketing strategies managers use to grow their customer
base. This qualitative case study and its design contributed toward a proposed solution for
the business problem. The rationale behind the leader selection was to identify strategic
decision makers and change agents from the manufacturing and companies. By
identifying participants from the marketing, sales, medical, and technology organization,
my expectation was to be then able to cultivate specific data from each with in-depth
interviews.
The qualitative research method was appropriate for this study. Because my
interest as a researcher was to secure reliable observations and gathering primarily verbal
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data rather than measurements, I chose the qualitative method over quantitative and
mixed methods. I also chose it because of the personal nature of this approach (Ritchie,
Lewis, Nicholls, & Ormston, 2013). Qualitative approaches to information gathering
focus on why and how questions and involve direct interaction with individuals in a oneon-one or group setting, whereas quantitative approaches focus on relationships between
variables (Silverman, (2013). Research which typically involves counting and classifying
as its attributes, is quantitative in nature. The Mixed Method Research blends both
qualitative and quantitative attributes and approaches.
A case study was more appropriate for this research than phenomenology,
narrative, grounded theory, or ethnographic design. A case study allows the researcher to
conduct an in-depth investigation of a single individual, group, or event. During the
exploratory research, it became evident that several individuals from different business
groups would be needed. A multicase study design with the qualitative approach was
determined to be the most appropriate design for this study. The research method
determined the planning and strategy points. In-depth interviews were the most
appropriate for collecting data on naturally occurring behaviors in their usual contexts.
In-depth interviews were one method of data collection used in this study (Muskat,
Blackman, & Muskat, 2012). In contrast, ethnographic is wider in scope and focuses on
the sociology of meaning through close field observations of sociocultural phenomena.
Phenomenology was also not appropriate for this study because it delineates itself from
any recourse to theory, deduction, or assumptions from other disciplines. Grounded
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Theory was also not a good fit because it focuses on research to understand the social and
psychological processes that describes an event or situation (Marshall & Rossman, 2014).
Research Question
The research question for this study was: What marketing strategies medical
device manufacturing company leaders use to expand their U.S. consumer customer
base?
Interview Questions
1. Would you describe how your company’s business model is open to
partnerships that promote innovation?
2. How does the U.S. automated defibrillator market compare to others in the
world?
3. How has your AED distributor network model evolved over the last few
years?
4. How far are we from having an AED in every home?
5. How will first responder services be affected in case of SCA with hospitals
moving from rural to metropolitan areas?
6. How is product affordability of AEDs for the aging senior consumer being
addressed by your company?
7. Would you describe your company’s perspective of AED Training Programs
as a product value-add for market growth?
8. How have AED recalls influenced your product design?
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9. Despite public awareness of CVD and large market share of AED sales in the
United States, why does CVD still account for over 340,000 deaths outside of
healthcare settings each year?
10. Would you elaborate on your company’s involvement in medical device
solutions for hospital treatment post-SCA?
Conceptual Framework
The conceptual framework for this study was the product life cycle (PLC)
theory. The PLC theory pursues the notion of a product’s market presence is like
organic life (Nadeaua & Casselmanb, 2008). The four life stages of a PLC in which a
product passes through are from inception to death. These four life stages include an
introduction, growth, maturity, and decline which distinctively share more market
characteristics with other products in the same stage than with itself at a previous or later
stage. Per Michael Grieves (1971), these stages are where a product perish and become
petrified. When infused onto organizational marketing strategies, PLC provides useful
insight into competitive tactics, an alternate perspective on how to address issues of
supply and demand, as well as those of time (Nadeaua & Casselmanb, 2008).
People manage organizations. Their influence and the decision-making culture
they created come from their behaviors. In 1928, Marston wrote in the book, Emotions
of Normal People, about how human behavior is not so cut-and-dry or black and white
(Marston & Moulton, 2013). The author then went on to describe the various types of
behaviors. While he did not write the Drive Influence Steadiness Compliance (DISC)
theory of personality styles, his concepts behind DISC are the framework of the theory.
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The theory later influenced the development of the actual DISC test (Marston, King, &
Marston, 1999). The decision-making culture of the participants was explored.
Dominance styles are typically early adaptors and leaders driving the first-tomarket culture in their respective organizations (Nadeaua & Casselmanb, 2008). The
problem-solving process for medical device manufacturers in the United States requires a
dominant approach by its marketing leaders to PLC. The dominant approach contributes
to growing their consumer customer base. The Product Life Cycle may augment open
business models. New business models allow outside ideas and technologies to be
infused and propagate onto their products and services. The infusion may augment their
economic potential (Chesbrough, 2012).
Definition of Terms
The operational definitions listed below are of technical terms, jargon, or special
words, in alphabetical order. Also listed are citations of definitions from peer-reviewed
articles/government websites.
Automated external defibrillator (AED): An AED is a computerized medical
device which can check a person’s heart as well as a potential shock it back to a normal
rhythm (AHA, 2014).
Boomer: The word boomer refers to the Baby Boomer population of those born
between 1946 through 1964. This generation is the Boomer Generation and portrayed as
a generation of optimism, exploration, and achievement with increased educational,
financial and social opportunities (Fingerman, Pillemer, Silverstein, & Suitor, 2012).
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Cloud computing: Cloud computing is the use of powerful computing hardware
for processing and leveraging high-speed Internet and software in smart mobile devices
to gain ease of application management and ubiquity (Armbrust et al., 2010).
eHealth: eHealth (also written e-health) is a term for healthcare practice
supported by electronic processes and communication, dating back to at least 1999.
Industry leaders and marketing personnel use this term rather than academicians. The use
of the term is in line with other e-words such as e-commerce, e-business, e-solutions, in
an attempt to convey the promises, principles, the excitement around e-commerce
(electronic commerce) to the health arena. The term’s use is to account for the new
possibilities the Internet is opening to the area of healthcare (Fox & Duggan, 2012).
mHealth Technology: Mobile healthcare technology is the same as mHealth. The
use of mobile devices for health-related behaviors and human metrics (Brown, Yen,
Rojas, & Schnall, 2013) is mHealth Technology. Health Informatics is MHealth
Technology. This technology is used as a survey on ambient-assisted living tools for
older adults (Rashidi & Mihailidis, (2013).
Myocardial infarction: Necrosis or destruction of a region of the myocardium
caused by an interruption in the supply of blood to the heart is usually because of
occlusion of a coronary artery. A myocardial infarction is a cardiac infarction (Meier et
al., 2013).
Smarthome: Smarthome is the term used to describe a home built with technology
infrastructure. The infrastructure may include telecommunication transport connectivity
with wide broadband capacity. It may also include Ethernet wiring and power sources as
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a premise to add technological applications. Telemedicine is one application used to
monitor patients’ vitals at home (Li, 2013). Voice communication and automated voice
recognition applications on devices, will present a system of vocal order recognition in
distant speech context. These features benefit the disabled and aging community at home
(Portet, Vacher, Golanski, Roux, & Meillon, 2013).
Spoofing: Spoofing is the creation of TCP/IP packets using someone else’s IP
address. Routers use the destination IP address to forward packets through the Internet
but ignore the source IP address. The destination machine uses the address to respond to
the source (Jafarnia-Jahromi, Broumandan, Nielsen, & Lachapelle, 2012).
Sudden cardiac arrest (SCA): Cardiac arrest, also known as sudden cardiac arrest,
is the abrupt loss of heart function in a person who may or may not have diagnosed heart
disease (AHA, 2014).
Ventricular fibrillation (VF): VF is an arrhythmia most commonly associated
with the onset of Sudden Cardiac Arrest (AHA, 2014).
Assumptions, Limitations, and Delimitations
Assumptions
An assumption is a supposition taken by a researcher as truth without actual
verification or valid reference. Assumptions may carry risk in this study (Silverman,
2013). My first assumption was that the qualitative approach was the most appropriate
method to explore the related factor. I also assumed that my selection of a multicase
study design was an appropriate one for this study. Another assumption was the
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participants selected would participate and provide honest responses (see Denzin &
Lincoln, 2011).
In this study, I also assumed that, despite sales growth of AEDs, medical device
manufacturing leaders are failing to equip the U.S. consumer markets proportionally and
were contributing to slowing down the continued growth of SCD. Sudden cardiac arrest
continues to be the number one killer of all combined deaths in America year over year.
The assumption was that medical device manufacturer marketing leaders are not aware of
the untapped emerging markets. Another assumption included the possibility that out-ofhospital defibrillator sales opportunities to the 65-year-old plus boomer population were
the most abundant market for growth in the consumer space.
The assumptions of this study also included some medical device manufacturing
and distribution marketing leaders not maximizing their market potential of their
consumer goods and have limited marketing strategies to expand their AED customer
base. Included in this study was a correlation between the high percent of U.S. homes and
public settings unequipped with an AED and the 88% of SCAs occurring in American
homes (AHA, 2012). The lack of AED sales to the U.S. homeowner will increase as more
of the retiring boomer population grows and ages, proving all assumptions to be true.
Limitations
A limitation is a limiting condition and restrictive weakness. A limitation also
lacks in capacity and the inability of the study (Locke, Spirduso, & Silverman, 2013).
Several limitations existed in this study. The first included the number of available
medical device manufacturers approved by the FDA of home AED models available for
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sale without a medical doctor’s prescription (Lenzer, 2004). The limitation is one
manufacturer spanning 2 decades through 2010. In 2013, two other AED manufacturers
were approved by the FDA, yet lack the manufacturing tenure of the top two
manufacturers. Also, because medical device manufacturing and distribution marketing
leaders have experienced high percentages of sales growth, they were, to an extent,
myopic to the 85% marketing opportunity in the consumer goods sector. The 85% is the
market growth remaining in the customer base citation?.
Medical device manufacturing and distribution marketing leaders determined their
sizeable sales growth (Frost & Sullivan, 2012) as effective outcomes of their marketing
strategies. Their sizeable sales growth, as the total potential for growth, may continue to
be a misperception and prevent them from an open consideration of new marketing
strategies. By not seeking to expand onto existing or emerging markets, a sales limitation
continues to occur. The assumed limitation that the prospective manufacturer marketing
leaders and its distributors, which are of European culture and business acumen, curtailed
open business models to be infused was confirmed. Their marketing strategies do not
allow infusing an open business model (Chesbrough, 2012). Marketing leaders continue
to decide not to leverage the product life cycle onto their organizational marketing
strategies to provide useful insight into competitive tactics (Nadeaua & Casselmanb,
2008). Using direct sales channels for the consumer market is where their ideology
varied and their approach to market penetration, pricing, and retailers’ product sales
management. In turn, distributors and sales channels are those entities with open sales
models, partnerships, and innovative initiatives.
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Delimitations
Delimitations are boundaries that researchers impose to focus the scope of a study
(Mitchell & Jolley, 2010). Some areas addressed include limited geographical location
and a brief period to collect the data. Delimitations are within a researcher’s control.
Delimiting factors occurring in the study include the choice of objectives, the research
questions, variables of interest, theoretical perspectives adopted by the researcher, and the
population the researcher chooses to investigate (Simon, 2011). In using selected group
of medical device manufacturing and distribution marketing leaders as a sample of
convenience, as opposed to a random sample, delimited the choice of the population to
investigate. The criteria in delimitating to a single firm were by leadership in U.S. market
share in the consumer segment and approval by the FDA.
By delimitating time and duration to conduct this study, I attempted to control the
scope of the study related to emerging markets driven by new technology conditions. The
scope changed to some degree in the interval of the study. In this awareness, the research
reflected data from the period and time of the interviews, corporate website, and data
assessment (Coutts & Jann, 2011).
Significance of the Study
Contribution to Business Practice
There is a substantial business value in maximizing sales to U.S. consumers and
emerging markets without AEDs or its bystander programs by the medical device
manufacturers and its distribution channels in untapped markets. One of those untapped
markets is the baby boomer retiree within the consumer market with only 15% having an

17
AED program (AHA, 2012). I explored potential marketing strategies to expand the
untapped 85% AED consumer markets. The number of AEDs sales trends in the United
States varies by researchers. Those researching AED trends from the largest medical
device manufacturers worldwide estimated that in 2014, 775,000 units were sold annually
to the public. These metrics represent an increase of approximately 30% per year
(Markets & Markets, 2014). The market will reach $12.9 billion by 2019 at CAGR of
6.9% from 2014 to 2019 or approximately 912,750 units (Markets & Markets, 2014). The
forecast period of 2014 to 2019 is based on the metrics from studies of the global
defibrillators market. My intended contribution from this study was to surface segments
of the consumer market where AED has its greatest potential for growth.
Based on this research, forecast dated as early as 2012 were already predicting
annual revenue for the automated external defibrillator market by the end of 2015 to be
$1.7 billion in the United States (Starr, 2012). The Global defibrillator market is expected
to reach USD 15.75 billion by 2020 with a compound annual growth (CAGR) of 7.89
percent over the period 2014-2019. The U.S. market share represented less than 1%
(Heidenreich et al., 2011) in 2011, yet Grand View Research (Grand View Research,
2015), forecasted to reach 10.7 percent share by 2020. This statistic supports the
fundamental business problem and the opportunity to increase U.S. market share within
the AED commercial and consumer goods by medical device manufacturer marketing
leaders with marketing strategies contributing to effective business practices.
Derivatives and findings from this study may influence manufacturing and
distribution marketing leaders to shift their marketing and sales strategies more
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effectively. Marketing leaders’ existing strategies, for most manufacturers in the United
States, include sustaining 70% annual sales growth (Frost & Sullivan, 2011) in the
existing markets, rather than exploring new marketing strategies and emerging markets in
consumer goods of medical devices. Since the beginning of this study, new strategies
have surfaced and will potentially represent a multibillion-dollar uplift in sales. Pseudo
AED U.S., April 5, 2016, news release supports the AHA recommendations for wearable
defibrillator use for the prevention of sudden cardiac death, is one example.
New product development and sales initiatives would accomplish what other
researchers have not in this area of business. Other researchers have not explored
emerging markets in the home and public settings, related to mHealth technologies. Other
exploration for market growth opportunities may include the aging population from the
U.S. baby boomers’ era. This shift of focus and paradigm on manufacturing and
distribution marketing leaders will bring meaningful insight and influence new strategies
and customer base growth to medical device manufacturing companies marketing in the
United States.
Implications for Social Change
The principle contribution toward positive change is to make a substantial
advancement toward the improvement of human conditions. The improvement is by
promoting AED programs for public access, home healthcare, out-of-hospital, and
cardiac monitoring to prevent the loss of lives to SCA. The objective was to uncover
AED manufacturer marketing strategies and its distribution channels that may yield justin-time AED access and bystander assistance in the first four minutes a victim suffers
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heart failure. Other authors and medical community leaders have addressed prevention by
Emergency Medical Service (EMS) dispatching (Go et al., 2014), and other measures for
cardiovascular disease. These measures include dieting, exercising, stress management,
reduced tobacco consumption, and surgical procedures of Implantable cardioverterdefibrillators (Roger, Go, Lloyd-Jones, & Benjamin, 2012). While these measures
contribute to the prevention of CVD, none addresses the prevention of SCD in the critical
first 4 minutes that SCA occurs in a victim.
The true business application of this current study is to pivot the attention and
resources toward solutions with timely responsiveness to the home and public AED
programs during SCA. Social solutions or medical research of the root causes of coronary
heart disease are more applicable to future cases and not for life-threatening solutions.
Preventive medicine for individuals and organizational leadership will have a paradigm
and ideology shift that will facilitate an opportunity for each to invoke positive change.
The principle effect of the positive change is to make a substantial contribution toward
the reduction of SCD victims and associated healthcare costs while contributing to the
individual quality of life (Greengard, 2013). This paradigm shift and new awareness will
help strengthen leadership accountability and innovation for reducing SCD and cost of
healthcare in the United States.
A Review of the Professional and Academic Literature
The purpose of this literature review was to provide an overview of relevant,
current, and previous studies, as well as a critical analysis and synthesis of various
sources with a depth of inquiry. A critical analysis and depth of inquiry include the
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increasing number of retiring and aging baby boomers to their homes and rural areas
coupled with their increasing needs for medical services. The purpose of the analysis is to
address issues surrounding the U.S. AED consumer market and its vast potential. This
review includes an in-depth analysis of the trends in healthcare with the demands for
hospitals to consolidate their presence and resources. The consolidation includes
hospitals moving from rural areas to metropolitan areas in rendering medical services to
the growing aging population.
The study includes a discussion of how this issue may create more market
opportunity and AED manufacturers’ marketing position. Included in the review will be
the product life cycle (PLC) theory. The theory pursues the notion of a product’s market
presence is similar to organic life use of a dominance leadership style. In the review, I
also addressed the rising cost of healthcare and the effect AED manufacturers potentially
have in its reduction. Other issues and potential marketing opportunities are part of this
review. The inclusion is specific to the dependency of accessibility and immediate
medical attention and its relation to AEDs with the knowledge that 88% of SCAs happen
at home and public areas. AEDs are an essential tool to restarting the heart and placement
to cover the greatest amount of area and is the responsibility of the medical device
manufacturers to provide approved models for home use. Automated External
Defibrillator manufacturer sales and distribution of their AEDs to the consumer market is
only 15% by all companies combined. There is an opportunity to explore the theory of
the misalignment in their market strategies and demand in new markets. As a result, there
is a curtailment of their business and social responsibilities. In this case study, I explored
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AED coverage in out-of-hospital settings to determine its current and growing
contribution to a $108 billion expense each year.
This literature review consists of scholarly and medical journals covering broad
issues related to marketing and sales outcomes of AEDs by medical device
manufacturers. Also included in the review are scholarly journals regarding strategic
marketing for AED customer base growth in the United States. This review also consisted
of trends in healthcare pertinent to demands forced on hospitals to consulate their
presence and resources in metropolitan areas as opposed to remote or rural areas
alongside associated industry issues. The literature review has content of trends and
forecasts from medical journal literature on the baby boomer population, the aging, and
its correlation with hypertension cases on the rise. The cases are among adults 65 years or
older and the upward trend of SCA.
Governance by the FDA and state governments was part of the review exploring
the contributing factors to bystander and training reticence. I also discussed research
regarding the FDA governance and recall compliance as well as over-the-counter
purchases and physician’s prescription. Last, the literature review includes open business
models, emerging technologies, and public awareness of AED programs.
I created this critical analysis and synthesis of various sources and content found
in journals, reports, and scholarly books mainly through Walden Library of business
management and technology professionals. I also used United States government
regulatory entities published documents and other scholarly resources. Databases
searched were: Business Source Complete, Lexis Nexus Academics, and Google Scholar.
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Search terms included: heart disease and stroke statistics, sudden cardiac arrest, lifesaving AEDs, bystander and CPR, randomized response techniques, baby boomer,
Association of American Retired Persons (AARP), defibrillation, Cardiopulmonary
Resuscitation (CPR), and emerging technologies.
My strategy in searching the literature included a clear understanding of the
general and specific business problem of the study. I identified the subject matters
associated with business, marketing, healthcare, aging population, emerging
technologies, and governance. Ensuring 85% total of peer-reviewed sources with a
minimum of 60 peer-reviewed sources for this literature review meets rubric criteria.
Also, that 85% of the total sources have a publication dated less than 5 years from the
anticipated completion date of study.
Within this doctoral study, there are 114 sources. Of the 114 sources, 107 or
93.8% are peer-reviewed. Seventeen sources that are more than 5 years of their published
date to the date of this study were included. The total sources 5 years of their published
date leave 97 sources dated 5 years or less of publishing from the date of this study, or
85.1%.
I have divided this literature review into five main subject categories. In the
business and marketing management category, I explored the perceived causes of medical
device manufacturing and distribution marketing leaders’ failures in maximizing their
market potential. I also explored the possibility of lack of awareness and use of an open
business model to allow outside ideas and technologies. The potential use of an open
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business model and its propagation onto their products and services, augmenting their
economic potential is a part of this review.
Last, I explored the past and current marketing strategies used to determine the
potential need to develop sustainable marketing strategies to expand their AED customer
base. In the healthcare and retirement trends of aging boomer population category, I
explored each trend to uncover root causes and potential pressure on the medical device
manufacturers to develop new marketing strategies in the consumer market of AED home
unit solutions. In the emerging technologies in medical devices category, I explored the
rising cost of healthcare attributed to SCA. In the final category, I explored security,
safety, and governance of AEDs.
Business and Marketing Management
PLC marketing with a dominance leadership style. Product Life Cycle theory
is the notion of a product’s market presence of a product is like organic life (Nadeaua &
Casselmanb, 2008). The four life stages of a PLC in which a product passes through are
from inception to death, where death is petrification (Michael, 1971). The four stages of
PLC are an introduction, growth, maturity, and decline. These stages are distinct as they
share more market characteristics with other products in the same stage than with a
previous or later stage. When infused onto organizational marketing strategies, PLC
provides useful insight into competitive tactics, an alternate perspective on how to
address issues of supply and demand as well as those of time (Nadeaua & Casselmanb,
2008). People manage organizations and their influence, and the decision-making culture
they created are from their behaviors. Marston (1928) in the book Emotions of Normal
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People, wrote about how human behavior is not so cut-and-dried or black and white. He
went on to describe the various types of behaviors. While the author did not write the
DISC theory of personality styles, the concepts behind are the framework of his theory
and led to the theory of the later development of the actual DISC test. These styles
include dominance, influence, steadiness, and compliance.
The theory and evaluation regarding those leaders with dominance as the primary
style with a potential blend of the other personality types affect their everyday actions.
These actions influence a culture in an organization (Nadeaua & Casselmanb, 2008).
Dominance styles are typically early adaptors and leaders driving the first-to-market
culture in their respective organizations (Nadeaua & Casselmanb, 2008). Given this
marketing theory and its relativity to the business problem, medical device manufacturers
in the United States will need to be open for a new business model. Manufacturers’
marketing leaders must lead with a dominant approach to PLC to grow their consumer
base. Leveraging PLC through marketing leaders will open opportunities to alter the
competitive landscape (Nadeaua & Casselmanb, 2008). Leading with PLC will also open
business models allowing outside ideas and technologies infused and propagated onto
their products and services. These efforts assist leaders in augmenting their economic
potential (Chesbrough, 2012).
Based on the percentages of sales by these medical device manufacturers, sales of
AEDs to the consumer market is only a 15% share of all companies combined. With
88% of SCAs occurring at home and public settings, combined with an 85% AED home
market potential, the opportunity remains in applying the PLC marketing theory to solve
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this business problem. The conceptual framework includes understanding the potential
cause for the lack of some medical device manufacturing and distribution marketing
leaders not maximizing their sales potential in the U.S. consumer AED markets. The
framework also includes a conceptual element regarding the potential correlation between
U.S. consumers and out-of-hospital facilities to AED programs. The correlation includes
leaving U.S. consumers at home and other out-of-hospital facilities unequipped with
AED programs. This void is an untapped market left open by AED manufacturer
marketing leaders. By leaving this segment of the market open, it contributes to the
increasing deaths associated with SCA and the financial effect on American businesses,
its consumers, and their experience and sensory systems (Achrol & Kotler, 2012).
Marketing opportunities to expand the customer base. Publications from the
AHA indicated that 88% of SCAs occur at home and in public settings (AHA, 2013). In
the workplace, 3% occur, according to the U.S. Department of Labor – Occupational
Safety & Health Administration (USDL-OSHA) records dating from 2003 to 2014. The
remaining 9% occurring in other out-of-hospital locations. The marketing opportunity to
expand the customer base is in the home consumer market. In the home is where 792 of
the 932 daily deaths attributed to SCA in contrast to only 27 cases in the workplace with
the remaining 81 cases in other out-of-hospital locations.
The Food and Drug Administration (FDA) has approved AEDs for home use
without a prescription by four medical device manufacturers in 2013. Homes are the least
equipped with AEDs or AED programs (Jorgenson et al., 2013) despite FDA approvals.
One U.S. manufacturer with such approval occurred in 2010 (USDHHS, 2010). In 2013 a
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second company received such approval and more throughout 2014. These FDA
approvals, alongside the untapped potential customer base growth of the baby boomer
consumer market, are evidence of a gap. This gap remains a considerably large marketing
opportunity for medical device manufacturers.
Despite awareness of defibrillation being the only effective treatment for sudden
cardiac arrest (Go et al., 2014) plans for a solution fail to exist. The AHA’s initiatives in
SCD prevention and the sales growth of AEDs to corporations and homeowners in
America falls short of the needed coverage. Less than 34% of the United States has
public access to an AED, and less than 15% of private facilities have an AED (AHA,
2012). With only 34% of public access to an AED, medical device manufacturing and
distribution marketing leaders are leaving a 66% of the market unequipped. The results
are similar for other consumers. The other consumers account for 85% of the U.S.
market. Segments of this market are private facilities and homes do not own an AED.
Trusted entities such as the AHA, AMA, Journal of Medicine, and by the medical device
manufacturers, distribute public information of this nature.
The U.S. AED market opportunity for growth remains open. When compared to
the global defibrillator market at $9.3 billion in 2012 (Frost & Sullivan, 2012), the
percentage represents only a fraction of the global market. The expectation in the global
market is growth at a compound annual growth rate (CAGR) of 6.2% from the year 2013
to 2019. Transparency Market Research (2012) forecasted an estimated value of $14.2
billion in 2019 North America, which includes the United States, Mexico, and Canada.
This forecast represents the largest market for AED, followed by Japan and Europe.
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North America and Japan forecasted to grow at a slower pace, primarily because of
saturation in the market. The expectation in the Asian market is to register maximum
growth over the next 5 years, based on the increasing installation of AEDs and rising
prevalence of cardiovascular diseases. Market values between the United States, Canada,
Mexico, Asia, and the globe may vary. As long as the potential of each respective market
excludes the home model AED in their forecast, the U.S. market will hold its value.
The market for AED has become dynamic with companies in this segment
adopting growth strategies of collaborations, agreements, and acquisitions. Emerging
markets and out-of-hospital defibrillators represent abundant opportunities for
stakeholders in this space. The AHA informed the public of decreasing survival rate. The
public information illustrated decreasing survival rates to only 9.5% of the 359,400 outof-hospital cardiac arrest incidents in 2013 in the United States. This decrease accounts
23.9% of adults and 40.2% for children in-hospital respectively for 209,000 incidents
(AHA, 2012). These statistics includes African-Americans as they are almost twice as
likely to experience cardiac arrest at home, work, or in another public location than
Caucasians. African-Americans survival rates are half of Caucasians (AHA, 2013).
African-Americans are much more likely to have diabetes, hypertension, a low
educational level, low income, and lower mean levels of physical activity (Taylor Jr. et
al., 2005). Women who are of Hispanic and African-American ethnicities are somewhat
more likely than men to experience some of the other common symptoms particular
shortness of breath, nausea/vomiting, and back or jaw pain. Symptoms as these are more
difficult to determine while warning others that SCA is occurring (AHA, 2014).
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Implementing open business models for AED manufacturers. This multicase
study was on multiple leading medical device manufacturers; AED distributors and
healthcare professionals in the United States. The study includes exploring factors
motivating marketing leaders from the leading medical device manufacturers to seek
assistance from experts to help develop more sustainable marketing strategies. These
factors may include infusing an open business model. This portion of the literature review
includes a discussion of the importance for medical device manufacturers to be in
knowledge of the magnitude of the AED marketing opportunity. Although the big three
U.S. manufacturers are augmenting their AED production, the question remains if they
are effective in targeting the consumer segment and use of marketing strategies. The
tendency of U.S. manufacturers to have proprietary business models and resident
intellectual property is symptomatic and inherent to the manufacturing industry. These
business models strengthen the company’s market share with their own patented
products. Automated External Defibrillator manufacturers are not an exception. Per
Chesbrough (2012), innovation inefficiencies occur when companies operate in close
business models lacking in exchange of technologies and intellectual property that is
necessary to the industry and its consumers. Firms can awaken their dormant economic
potential using outside-in perspectives and open to infusing outside ideas. By combining
the use of internal technologies as well as a willingness to allow internal technologies to
flow to the outside.
Rising cost and shorter timetables in design, production, distribution, and
technology development are costly and time- consuming factors (Chesbrough, 2012) for
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medical device manufacturers. FDA requirements and approvals are factors affecting
AED manufacturers. FDA approval results in an additional delay if there is a history of
recalls. D.M. Zuckerman, Ph.D. (2011); P. Brown, BS (2011); S.E. Nissen (2011), MD,
reviewed the FDA approval process (2011). They concluded that medical devices passed
through the less rigorous FDA 510(k) clearance. Medical devices comprise more than
two-thirds of the products recalls by the FDA. This process harms patients or results in
death. When devices were intentionally exempt from any FDA review were added to the
FDA 510(k) approved and classified devices, they comprise more than 3 out of 4 of the
high-risk recalls during the last 5 years. Their findings reveal important shortcomings in
the current FDA device review system and its implementation that will require either
congressional action or major changes in regulatory policy.
This FDA device review makes it increasingly difficult to support investments in
innovation that result in added manufacturing pressures. These pressures include the cost
of new product development and the expected revenue from sales to cover the cost of
conducting business and achieving innovation. By applying an open business model, new
brands of licensed technologies from other companies (Chesbrough, 2012) may generate
millions of dollars in revenue and improve companies’ expenses before interest, taxes,
and amortization (EBITA). Open business models contribute to an increase in revenue.
These business models were a point of discussion during the interview as part of
motivating medical device manufacturers to consider an open business model.
Baby Boomer strong buying potential and greatest need for home AED
solution. The baby boomer has a combined consumer buying potential of $3 trillion
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(Parment, 2013). This constituency of consumers has the buying power and aware of
more technical and digital devices and applications are part of the American culture
(Behrens, Mislevy, DiCerbo, & Levy, 2010). Many retirees with financial resources are
relocating to more remote and suburban locations. Given the trends of the aging and
those of healthcare, the aging baby boomer may be at a higher risk than ever before.
American Heart Association’s (2011) CPR statistics shows nearly 383,000 out-ofhospital sudden cardiac arrests occur annually and 88% of cardiac arrests occurring at
home. Over 932 deaths occur each day to SCA (FDA, 2013) with approximately 792
occurring at home. If a home for the aging baby boomer is in a remote location, it implies
a higher risk because home is where AED manufacturers have grown their customer base
the least. There is less focus on marketing and sales strategies of AED home model, as
well as minimal training programs by AED manufacturers to solve this issue.
Although AED manufacturers’ marketing strategies include retail, over-thecounter, and Internet sales by direct distributors, the marketing gap remains in both
commercial and consumer markets. The AHA estimates more than 95% of cardiac arrest
victims die before reaching the hospital. The lack of market penetration of these markets
reduces accessibility to an AED and decreases a victim’s chance of survival. This
reduction in accessibility to an AED reflects the weaknesses of previous studies and its
outcomes.
Growing incidences of cardiovascular diseases and disorders, combined with the
aging of baby boomer population entering their 65th birthday since 2011, are contributing
to the growth of the U.S. defibrillators market. Concurrently, operating expenses
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alongside market demands are forcing hospitals to consolidate their resources and
physical presence in metropolitan areas as opposed to remote or rural areas. The aging
population has the tendency to relocate to more remote areas (Oswald & Rowles, 2006)
for peace and quiet, yet medical facilities are relocating to metropolitan areas. This
relocation factor reduces first-responder and emergency resources to the aging population
(Shabel, 2014). This remote living is especially concerning because these individuals
depend on ease of accessibility and quick response for urgent medical attention. Retiring
in rural areas for the aging boomers may not be a good option if these trends continue.
This trend is an opportunity for medical device manufacturer marketing leaders to seize
the trend by solving the issue using mHealth devices and technologies for the rural home,
home healthcare, and retirement home facilities. One opportunity may involve the impact
of mobile devices and how these devices are transforming healthcare and the
development of new medical devices (West, 2012).
The market demands safe and easy to use features, as well as emerging
technologies in out-of-hospital markets (Lewis & United States Food and Drug
Administration, 2001). These features may be in concert with the boomer population
which is more digitally centric (Oblinger, 2008). There are increasing trends toward
installations of AEDs at workplaces by direct sales channels. No trends of AEDs home
sales, installation, or training programs exist. This trend is a good opportunity for growth
in the defibrillators market. With boomers, more digitally centric, coupled with no
product recalls since 2010 (FDA, 2010), the opportunity for growth prevails.
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Cost and risk of Healthcare in rural areas. As boomers begin to purchase
retirement homes, the ideal landscape may include finding a rural area or small American
town where they may find peace and serenity during their last years of life. Populations
living in rural areas may have a risk for the aging and retiring boomers if they are not
healthy (Shabel, 2014). Per Shabel (2014), the healthcare market demand for hospitals is
forcing them to consolidate their presence and resources in metropolitan areas as opposed
to remote or rural areas. This shift is especially concerning to the aging and boomer
population because they depend on ease of accessibility and quick response as they may
encounter cases in need of immediate medical attention. Some may advocate healthcare
policymakers to the lobby and take action to ensure provisioning of medical resources to
rural medical communities. This advocacy and awareness may be the opportunity for
medical device manufacturer marketing leaders to seize the trend by solving with
mHealth devices and technologies for the aging at home (Reeder et al., 2013).
Medical doctors and advocates such as Graham Nichol, Alfred P. Hallstrom, and
Richard Kerber, have proposed defibrillation solutions in public places in which large
numbers of older people are present (Nichol et al., 1998). Other experts in the field such
as Myron L. Weisfeldt, M.D., Siobhan Everson-Stewart, Ph.D., Colleen Sitlani (2013)
have concluded differently as their perspective is in medical terms. They evaluated outof-hospital cardiac arrests in which 2042 occurred in public and 9564 at home during the
same period of time. Their conclusion was that regardless of whether out-of-hospital
cardiac arrests are witnessed by EMS personnel or bystanders and whether AEDs are
applied by bystanders, the proportion of arrests with initial ventricular fibrillation or
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pulseless ventricular tachycardia is much greater in public settings than at home. The
incremental value of resuscitation strategies, such as the ready availability of an AED,
may be related to the place where the arrest occurs.
The study underscores the number of cases at home and in need of equipment and
bystander training, to be applied in much the same way as for the public, to prevent SCD.
The AHA has also advocated Medical device manufacturing and distribution marketing
leaders to assist with SCD prevention in this space. Nevertheless, manufacturers are still
leaving their largest opportunity in the consumer market unequipped and at risk with an
estimated 85% potential in the home and public settings (AHA, 2012).
Starts at home: An untapped potential market. Per the AHA (2014), 70% of
Americans may feel helpless to act during a cardiac emergency because they either do not
know how to administer CPR or an AED. Home is where 88% of cardiac arrests occur
(AHA, 2013) and continues to be the alarming statistic. The FDA approved
manufacturers to market an over-the-counter AED for home use (Mayo, 2015). This
approval contributed to the overturning of regulation, which enforced the use of
prescriptions. This regulation is no longer an obstacle to purchasing or using an AED at
home.
Automated External Defibrillators are not prevalent in homes where the initial
intent was to protect the aging or ailing individual. The home is where training and
accessibility are at its minimum. Aging individuals is a potential market segment and
issue unrecognized by medical device manufacturing and distribution marketing leaders.
Statistics from both the AHA (2013) and FDA (2013) explicitly show more than 900
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lives lost daily to sudden cardiac arrest. Yet initiatives to reduce SCD have not
succeeded. Using Public Access Defibrillation (PAD) programs to assist SCA victims
have not been an effective initiative. Focused and targeted marketing campaign by
medical device manufacturer marketing leaders to capture the 88% of SCAs occurring at
home, may be a more effective method. The limitations with bystander training support
are a direct correlation to the statistics in the home and the lack of AED purchases by the
homeowner.
A more relevant and progressive medical device industry focus is on implantable
cardioverter-defibrillator (ICD) technology as opposed to AEDs. This issue, coupled with
the medical industry’s emphasis on preventive medicine, deters from AED and AED
program advancements. By medical device manufacturer marketing, designing, and
selling devices which provide medical assistance to patients with CVD history, the
detraction from developments in the consumer AED space will continue. This strategy is
reducing the potential to prevent SCD at home and provide first-responders with an AED
solution with accessibility to the victim within 4 minutes in the critical minutes needed.
This level of accessibility will take innovation and the ability to implement the
technology through entrepreneurship and leadership. To summarize the opportunity, the
combination of an open business model to seek new marketing strategies for the
consumer goods sector may be the motivating factor. The motivating factor is for medical
device manufacturer marketing leaders to seize the opportunity by growing their
customer base with the baby boomer market.
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Home AEDs. Home AED units are manual, mobile, with the ease of use built in
averaging in price from $950 each for a low-end model to $1,200 to $2,900 for those with
additional and automated features. Retailed by online distributors, pharmacies, and other
medical device sales companies, their inventory includes well-known AHA endorsed
brands. Their value proposition features manufacturer’s warranty, turnkey solutions
alongside the needed equipment to install AEDs at home. Training is an area which does
not always come with the home AED solution and yet a critical part of a bystander
assisting at home.
According to The New England Journal of Medicine (2011) in 7,000 people who
had a heart attack, a study showed in which one group received family training in
cardiopulmonary resuscitation and a 911 call strategy. In the same study, a second group
received AEDs and training to use them at home. The authors addressed the perception of
some bystanders who involve themselves with the use of the AED and not make the 911
call before engaging. After 3 years of follow-up, the authors concluded the researchers
found the high-tech group had no better than the “call 911″ group because of bystanders’
responsive attributes.
This study, supported by the National Heart, Lung, and Blood Institute, teaches
doctors a few new lessons, aside from answering the primary question regarding survival
in the two groups. The first lesson resulted in modern post-heart attack care had made
considerable inroads in preventing late sudden cardiac death. Instead of the 4% per year
death rate expected, the latest study documented sudden death rates closer to 1% per year.
Only about a third of the deaths in this post-heart attack population occurred because of
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rhythm problems treatable by the AED. Last, a third of the deaths were from non-cardiac
causes.
In both groups, training was an important part of taking the proper action in an
emergency either beginning CPR while calling 911 or using an AED. The importance of
each situation is a trained bystander to use any of these options given the circumstances.
If SCA was the emergency, the patient is without a pulse and an AED is the only device a
bystander uses to bring back a victim to life (Capucci et al., 2002). By applying the AED
within the first 4 minutes of the arrest, the survival rates for an SCA victim increase. If
the emergency involves a victim who has stopped breathing yet has a pulse, CPR may be
the best application.
The home continues to be a space where most SCAs occur and yet has the lowest
percent of AEDs and trained bystanders. Retailers and online, direct sales companies are
not providing the necessary marketing, training solutions, and awareness to motivate
consumers to purchase AEDs for their home. The cost associated with the purchase of a
new AED home model deters buyers from making this decision a priority. The
Association of American Retired Persons (AARP) does endorse the authorized
manufacturer of home AEDs. Despite the lack of endorsement, no joint marketing
initiatives exist informing and promoting the critical need of owning and AED most
especially for the boomers.
Cost-effectiveness and affordability of in-home AEDs. Direct sales channels to
the consumer market include Internet sales, local pharmacies, and retail stores for those
home model AEDs not needing a doctor’s prescription (AHA 2014). Home and small
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business model AEDs made by a U.S. manufacturer are readily available for purchase
ranging from $900 to $2,900 as well as accessories as over-the-counter products at retail
pharmacies. As early as 2004, the FDA allowed the sale of automated external
defibrillators (AEDs) from approved manufacturers. During the same period, an approved
class III medical device was the only one available for purchase with a prescription.
Over-the-counter (OTC) sale approval of AEDs belonged to one manufacturer. The FDA
approved a second manufacturer for an equal AED class, and the list continues to grow
(Jorgenson et al., 2013). One criterion to secure FDA approval is the safety and efficacy
of OTC AEDs purchased for the use at home. By 2009 many of the recall and safety
issues previously reported had been overcome by the AED manufacturers.
Notwithstanding, the need for an AED in the home to help prevent SCD remains a
marketing opportunity for manufacturers already approved and dominant in the
marketplace. While the largest opportunity in the consumer market is with the aging
population, anyone is subject to an SCA. The benefit from purchasing, training on its use,
and possessing an AED readily available during an emergency, is prevention.
Defibrillation is the only effective treatment for sudden cardiac arrest (Go et al., 2014),
and yet less than 15% of homes own an AED. The evidence of lack of sales and
proliferation of the AED is that Americans are still dying annually of sudden cardiac
arrest. It is more evident with 88% of all SCAs in the United States occurring at home
(AHA, 2013). The opportunity to expand the market is evident with these metrics.
Medical device manufacturers and its distributors will need to find ways to make home
AED units more affordable; be more engaged in their direct sales network, and build
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partnerships with vendors which core businesses in consumer products for the aging
population.
AED distribution network and its products. Leading AED manufacturer use
distributor networks as their sales footprint to capture volume of single unit sales. By
surfing the Internet for distributors, leads to manufacturer landing pages and online stores
selling their AED products directly. Distributors typically promote the implementation of
the AED in dental clinics, medical facilities, schools, churches, police, and all public
places (Palmero, Dotterweich, Lhotsky, & Walker, 2012). The marketed devices may
include features such as the use audible speech commands and viewable signals to lead
the rescuer through a resuscitation cycle that may include defibrillation and
cardiopulmonary resuscitation (CPR). Certain units use rectilinear biphasic defibrillation
waveform, and functions in either adult or pediatric modes and include both adult and
pediatric defibrillation electrode pads.
Manufacturer designs and marketing include devising the AED with nervous
rescuers’ in mind because most may be experiencing it for the first time. Engaging
bystanders willing to assist, AED features such as soothing voice, guides the rescuer
through the crisis with simple step-by-step instructions is a help and a good marketing
attribute for an AED. One important feature attracting prospective clients is the AED’s
ability to distinguish the force needed to compress the chest during CPR. Every person
has a different weight and physical ability. The standard measurement of chest
compression quality is not a force but the depth of the compression. These features
provide ease of use and minimize error. All are good designs for ease of use and
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expedites the process (Hallstrom & Ornato, 2004). The combination of the AED and CPR
are the most effective in assisting a victim of SCA.
In a real-world situation when someone has collapsed, potentially from SCA, a
quick installation of the AED will begin to analyze whether a shock is necessary. In 50%
of the cases to resuscitate a patient, the shock is not required. Other designs include a
one-piece electrode to accommodate the anatomical variation. Based on extensive
research, some AED manufacturers meet the anthropometric chest characteristics of 99%
of the population.
AED product attributes. During a crisis, simplified placement creates
confidence and calmness during the critical minutes. By affixing two separate electrode
pads to the patient’s bare chest, may be confusing to a lay rescuer. Some manufacturers
have simplified this step by guiding the placement of red crosshairs at the center of the
patient’s chest. Typically, the crosshairs have a hand-locator and two electrode pads
falling naturally into an optimal position for both defibrillation and CPR. These features
streamline the process and simplify the bystander’s actions. All AED electrodes transmit
defibrillating electricity into the patient through metal contact patch with a salt-infused
gel applied to the patient’s chest. Over time, the salt in the gel will corrode the metal and
eventually compromise the electrode’s functionality. Some AED manufacturers include
novel electrode design includes a special barrier preventing most corrosion for five years
or more (Fries, 2012). Last, defibrillators use lithium batteries are readily available in
most stores. They typically are good for five years and included with the unit.
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Other features found from different AED manufacturers include a simple to
operate turns on with easy-to-use pull handle. These become standard features, and
design brands come as ready-to-rescue features. The AEDs installed in the carrying case,
and battery and pads installed on the device as standard features. Some smart units
deliver maximum shock strength using a unique combination of high current to maximize
effectiveness and a lower energy dose to minimize side effects harmful to a fragile heart.
AED quality control. Part of quality control, in most AED manufacturers,
includes a 120-point test before it leaves the factory. Each AED conducts self-tests every
single day. The AED performs over 80 different tests in all as well as the pads. The quick
shock feature is a readiness test. This minimizes chest compression interruptions. CPR is
more important to survival than previously realized, rapidly delivering shock after chest
compressions are critical. This feature reduces the time between hands-off and shock
delivery. The integrated pad test for their sensing application to the skin is their ability to
sense from the cartridge and applied to the patient. The feature assures quality because it
helps the first responder know what point the user is in the response process. Last,
commonly graphics-based visual instructions with intuitive icon-driven operation and
design must communicate instantly with minimum reading and interpretation. Users not
familiar with the devices can follow the instructions easily. The quality control must yield
the necessary metrics to pass manufacturer and FDA approvals (FDA, 2013).
Medical Device Manufacturing of AEDs for the Consumer U.S. Market.
Boomers have long been the catalyst of the aging population by living longer (AHA,
2013), requiring quality of life and treatment option outside of the hospital, and medical
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facilities when chronic conditions occur. Thus, home healthcare has required medical
diagnostic and treatment devices with the capability to access remotely by sophisticated
computer-controlled electromechanical measurement instruments. These medical devices
located in advanced laboratories (Salditt & Bothell, 2004) are to accommodate consumer
demand. As of 2005, medical device manufacturers have monitored the trend in medical
devices for their design and manufacturing. Some trends include a tendency toward
smaller, user-friendly, more portable products that require more advanced components.
Innovation and scientific advances in manufacturing technologies and automation
techniques add value to remain competitive. Medical products covering the range of
patient monitors, drug delivery systems, therapeutic devices, and life assist devices all are
shifting from the care of in-home medical personnel to medical facilities. The use of
devices and telecommunication remotely connected provides access to in-home patients
to these devices.
Aside from implantable devices such as an implantable cardioverter defibrillator
(Bardy et al., 2010), new products are patient portable and patient wearable.
Manufacturer designers are also responding to market demands for low-power
components, long-life rechargeable batteries, rugged designs, simple user interfaces, and
low cost (Salditt & Bothell, 2004). User interfaces may be an area of further research
because many of the mobile applications and Internet connectivity is in telematics.
Medical device manufacturers marketing leaders and distributors of AEDs have
an unlimited opportunity in both technology and design to expand in the consumer goods
sector of this market. Coupled with an open business model approach, marketing leaders
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will substantially expand their customer base and remain mindful of the statistics stated
by the American Heart Association. Statistics includes an 88% of SCAs occurring at
home and public areas (AHA, 2013). Only 3% occur in the workplace according to the
U.S. Department of Labor – Occupational Safety & Health Administration (USDLOSHA) records dating from 2003 to 2014. The remaining statistics include the 9% of
SCAs occurring in other out-of-hospital locations. Based on the AHA (2013), the aging,
which includes Boomers, are going into retirement requiring healthcare at home and not
in the hospital or clinics. Because of this fact, medical device manufacturers of AED
home units increase their total market position.
Healthcare and Retirement Trends of Aging Boomer Population
The aging population from the Baby Boom era is retiring. The Boomer
Generation represents approximately 76 Million Americans born between 1946 and 1964
(Pruchno, 2012). The first of the baby boomers reached the retirement age of 65 in 2011
and the last group turning 50 in 2014 with women representing approximately 52% in
both groups. Per AARP (2014), boomers will turn 65 at a rate of about 8,000 a day for
the next 18 years. This sustained trend of a daily number of retirees will be the
approximate number spending more time at home. Retirees may potentially be falling
into the 88% of the SCA occurring at home with only a small amount of them equipped
with an AED.
Given the large volume of Americans, the Boomer Generation will influence and
transform the institutions of aging and many others in this era (AARP, 2014). What we
do not know is whether boomers redefine this period because of their large number,
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buying power, or management of the boomer market as they enter their aging years. This
unknown factor may be the redefining point in which medical device manufacturing and
distribution marketing leaders seize the opportunity to grow their customer base by a new
approach and strategic marketing plan.
The growth of the aging population and SCA cases at home. Approximately
8,000 or rather 240,000 of these baby boomers retiring per month from the current U.S.
population of nearly 320 Million (U.S. Census, 2014). Those boomers who are 65 years
old or more represent nearly 33% of deaths from CVD. These deaths are occurring before
the age of 75 years, which is well before the expected average of life 77.7 years (LloydJones et al., 2010). The 10-year window represents the boomer’s life span from the time
they reach 65 to their expected death at 75. The window provides the largest marketing
opportunities to this consumer by AED manufacturers to grow their customer base. The
life span for the 76 million boomers is 28 years of sustained customer growth potential.
The first boomers born in 1946 reached age 65 and the last born in 1964 reached their
75th birthday. This statistic represents 28 years of profitability for any company
marketing products and services to the Boomer Generation.
Emerging Technologies in Medical Devices
Medical Devices – Standardization of healthcare applications and decision
making. In the beginning years of networking, various network protocols,
telecommunications carriers and transport devices, computer operating systems, and data
formatting varied. Military, private, and public networks in the world operated in their
space. A similar case occurred with a technology platform. The principal was that by
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agreeing on a single protocol, all connect and communicate with one another. This
agreement was the marvel of how in 1997 Vinton G. Cerf. widely known as a father of
the Internet and co-designer with Robert Kahn of Transfer Communications Protocol/
Internet Protocol (TCP/IP) and basic architecture of the Internet, orchestrated the idea. In
much the same way, Albrecht (2012) recommended the standardization of medical
applications. Under one platform in a domestic and international setting, all users have
transparency of healthcare applications for trust and decision making (Rajagopal &
Ramanan, 2011). This concept can yield many benefits to consumers and patients.
In the future, standardization will be more prevalent because intelligent devices
such as smartphones and tablets integrate medical applications. Enhancing medical
applications and devices augment patient safety and information assurances, as well as
governance, are considerations for medical device manufacturer marketing strategies. It is
important to engage end users during the development stages of their products.
Deploying effective and transparent communication plans which inform and support
product specifications, applications, and safety, are additional steps medical device
manufacturer may consider in their portfolio of marketing strategies.
The AED and its measurement and locating limitation. Per the Food and Drug
Administration (FDA), there are about 2.4 million AEDs installed and mounted in
protective cases in private and public facilities across the country (FDA, 2013). The
average AED has an expected lifespan of five to ten years. Most AEDs are not used
within their life span. Not much wears out on these units. Manufacturers recommend a
monthly check for operability and updates if they have digital intelligence. The AEDs
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have the intelligent to notify when they have failed. The intelligence is an area of
engineering improvement and part of my patent. The United States alone is losing more
than 900 lives each day because of sudden cardiac arrest. Finding an AED using search
and find technology, in the community, is important in preventing SCD. Per a study
presented at the American Heart Association’s Scientific Sessions (2015), most public
automated external defibrillators are in buildings that are not open 24 hours a day. Thus,
bystanders who may be near AEDs have limited access to the life-saving defibrillators in
21 percent of out-of-hospital cardiac arrests. In this study, researchers analyzed cardiac
arrests that occurred within approximately 300 feet of a public AED.
Information gathered from studies conducted by the AHA (2012) requiring the
installation of AEDs for public access defibrillator (PAD), is a driving factor preventing
SCA fatalities to continue to grow. Legislation and advocacy are other driving factors in
the prevention of SCA fatalities (Gilchrist et al., 2012). There is also the potential for
closing the gap in time by using mHealth or AED technology to notify the 911
dispatcher. The SCA victim would have a chance of survival. Even if the technology
existed, the average time of eight minutes for a 911 response unit to be on-site is longer
than the life expectancy after an SCA (AMA, 2013). Last, there is also a gap in the actual
measuring and analyzing the national coverage area and effect of bystander AED
emergency response model. The existence of this gap makes it difficult for policymakers
and the national healthcare community to manage.
AEDs and the perception of a benefit or a burden. According to the AHA’s
chain-of-survival process (Fothergill et al., 2013), someone should immediately call
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emergency medical services, and a bystander trained in cardiopulmonary resuscitation
(CPR) should assess the victim in need. If an individual shows no breathing and no pulse,
the trained bystander should start chest compressions and ventilation such as CPR. The
purpose of CPR is to deliver oxygen to the blood and to pump manually the oxygenated
blood to the brain and other organs. CPR provides basic life support until advanced-lifesupport providers take over. If the victim is in cardiac arrest, performing CPR will not be
enough. An AED is applied in the first four minutes of an SCA.
Security, Safety, and Governance of AEDs for the Bystander and First-Responder
The bystander is important to a successful AED Program. Per Go et al., (2014),
EMS personnel treat approximately 60% of out-of-hospital cardiac arrests. These firstresponders are medical personnel certified to conduct CPR and AED application when
necessary. Trained and equipped Emergency medical service (EMS) personnel are vital
for these types of emergencies. Their limitation as a first-responder is their inability to
reach SCA victims in the critical minutes after SCA occurs. Their training in security,
safety, and governance of AEDs protects their employers and themselves from potential
negligence under standard conditions. Bystanders who first respond by coming to the aid
of an SCA victim run various risks by engaging with the public. These risks are part of
the 60% of out-of-hospital cardiac arrests. Not included in the Go (2014) study, is a
metric recorded when delineating SCAs occurring in the public facilities from those
occurring in other location and those with cases occurring at home.
To solve this issue, from a total out-of-hospital perspective, the AHA (2013)
published an advisory. The advisory recommended improving bystander CPR/AED

47
programs in communities with low bystander response performance (Bradley & Rea,
2011). The effort was to evaluate the effect of community-based CPR training programs
which in the United States ranged from 10%–65%. These initiatives are for the public
and nonspecific to homes needing a very specific training and bystander CPR/AED
program. While the intent was increasing cardiopulmonary resuscitation provision in
communities with low bystander cardiopulmonary resuscitation rates, the program did
not make a significant difference in the outcomes and metrics toward reducing SCD. The
connection between out-of-hospital SCA incidents and the fact 88% of all SCAs
occurring at home failed. The American Heart Association focuses on healthcare
providers, policymakers, public health departments, and community leaders (AHA,
2013). Yet this organization remains an important part of the bystander program and a
resource for those of us at home. Regulatory commissions, such as the FDA, have
established safety-surveillance strategies that rely on physicians, healthcare institutions,
manufacturers, and patients to report medical device failures and complications through
the Medical Device Reporting system. This reporting functions as an additional step in
governing critical medical devices such as external and internal defibrillators (Resnic &
Normand, 2012).
Many traditional AED/CPR courses are provided by the Red Cross, the American
Heart Association, private companies, as well as online courses on the Internet. These
AED/CPR courses are for community and workplace participants like teachers, coaches,
camp counselor, school bus drivers, personal trainers, daycare workers, babysitters, as
well as construction workers and others. The courses vary in time to complete, although
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most courses are approximately 45-60 minutes. The assumption that students trained
under this AED/CPR course content are professionals would not be accurate. The
assumption that a quick refresher AED/CPR course will provide expertise would also not
be accurate. The assumed correlation between heart attacks and cardiac arrest with aging
adults, or those with known heart issues, may be misleading. Unfortunately, anyone can
go into cardiac arrest without warning. Another characteristic is not tailoring these
training programs specifically to families with knowledge of how to be an effective
bystander. The truth is that litigation is always a potential issue despite the protection of
the Good Samaritan clause. Skilled personnel acting as bystanders, in best-performing
nursing homes settings, are also sued. The hope is to subvert someday the capacity of
litigation to provide incentives to deliver safer care (Studdert, Spittal, Mello, O’Malley,
& Stevenson, 2013).
Saving a life is as easy as opening an automated external defibrillator (AED)
located in almost every public building and workspace. The AED and a bystander are the
only medical solutions known to resuscitate a victim during SCA (Go et al., 2014). As
previously mentioned, 88% of all out-of-hospital SCAs occur at home (Go et al., 2014).
Yet less than 15% of homes have an AED (Go et al., 2014). Current research indicates
the chance of surviving SCA improves by 70% by applying an AED within the first 3 to
5 minutes (Go et al., 2014). In these few minutes, the best resources and trained firstresponders do not make it in time.
In the athletics arena and school campus settings, it is recommended by the
American Heart Association (AHA, 2013) that AEDs be part of an Athletic Trainer’s
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emergency action plan. Action plans as these alongside classroom-tested kit empowers
educators to teach CPR to hundreds of students. In most university campuses, the athletic
trainer has an AED accompany them with additional units accessible on campus.
According to the American Heart Association, more than 250,000 people die every year
from sudden cardiac arrest. Up to one in every five of those deaths is preventable with a
defibrillator. Campus personnel and athletic department trainers effectively apply AED
and CPR within 3 to 5 minutes if they are the first person on the scene. In the same way,
a home AED must include an AED program with the AED unit. Automated external
defibrillator manufacturers have the option of initiating solutions. The chain-of-survival
community is one option which provides resources and entities such as the Red Cross,
and the AHA.
Transition and Summary
In Section 1 of this study, I covered the fundamental issues surrounding the
limitations of current marketing strategies by medical device manufacturing company
leaders to expand their U.S. AED customer base. I also discussed its relationship to the
market potential and several U.S. homes without (Frost & Sullivan, 2012) AED
programs. The research study statement underscores the general business problem with
medical device manufacturing and distribution marketing leaders not maximizing a
potential in the U.S. consumer AED markets.
The specific business problem describes a shortcoming by the medical device
manufacturing company leaders possessing limited marketing strategies to expanding
their AED consumer base. An overview of the issue described in this study includes
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potential reasons and repercussions. The overview includes deprivation of just-in-time
defibrillation to SCA victims. Various literature review and data uncovered several
research options. One option is the qualitative approach to capturing in a multicase study
manufacturer marketing leaders’ business model, behaviors, and marketing strategies.
This approach infuses and influences an open business model and focus on the home
AED as a target market. In Section 1, I also covered relevant past and current studies
surrounding the concept AED programs, regulatory issues, and its relationship financial
performance of AED manufacturers and healthcare cost savings. Section 2 includes the
purpose statement, role of the researcher, participants, as well as the research method and
design. Section 3 includes the analysis, discussion of results, as well as potential
implications for business practice and social change.

51
Section 2: The Project
Since 2010, medical device manufacturing and distribution marketing leaders
have experienced a substantial increase of AED sales in the U.S. market (Frost &
Sullivan, 2012). This experience has predominantly been from an increased public
awareness of SCA, defibrillation, and a ubiquitous need across community landscapes for
accessibility to AEDs and its training programs (AHA, 2014). Interest by various
stakeholder groups regarding preventive health against CVD and CHD have all
contributed to the increase in sales by pursuing their respective needs and initiatives.
Stakeholders include companies seeking their interest in safeguarding their employees;
U.S. government’s initiatives of AED placement in public facilities; and the public with
community-based PAD programs.
Despite public awareness and programs throughout the medical community and
public sector, some medical device manufacturing and distribution marketing leaders are
not yet maximizing their sales potential in the U.S. consumer AED markets where most
SCAs occur. The lack of maximizing their sales potential is creating an abundant
opportunity for a nonservice customer base growth. It appears that medical device
manufacturing company leaders may have limited marketing strategies to supply the
expansion of the AED customer base.
Through this multicase study, I explored marketing strategies and business
models in an effort to uncover medical device manufacturing company leaders
perspectives on these concepts and approach to expanding their U.S. AED customer base.
I also explored the market potential of U.S. unequipped homes public settings (Frost &
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Sullivan, 2012) with AED programs. Outcomes from this research may include the
uncovering of new marketing strategies and business model opportunities for AED
manufacturers. Other outcomes may include identifying emerging AED markets,
improving survival rates, and improving the quality of life for SCA victims. Other areas
explored include emerging technologies and contributing towards reducing healthcare
costs.
Purpose Statement
The purpose of this multicase study was to explore the marketing strategies
medical device manufacturing company leaders use to expand their consumer customer
base. The research method is qualitative with a multicase study as the research design.
The population included medical device manufacturing marketing professionals from the
top 3 U.S. companies, its distributors, and healthcare professionals. During the research
and interviews, it was determined that while they were aware that the consumer base was
expanding, their marketing strategies were not focused on this space.
A qualitative multicase study is a valuable method for research to develop theory,
evaluate programs, and develop interventions (Baxter & Jack, 2008). The subset of the
sample was the company’s consumer goods division responsible for the U.S. market.
Expected outcomes of the research include convincing corporate leaders of their potential
and financial gain. The sample may also contribute to business growth in the medical
device industry and assist in reducing the $100 billion in annual expense for U.S.
consumers (Heidenreich et al., 2011). As part of social change, the use of AEDs may
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prevent the loss of the lives of more than 350,000 SCA victims dying annually of which
88% are occurring at home and within public settings (AHA, 2013).
Role of the Researcher
The data collection process for this qualitative study includes interviews with
AED manufacturing marketing, distribution leaders, and healthcare professionals, as well
as reviews of companies’ website material, analyzed data, and the findings. The purpose
of the interviews was to gather objectively relative information and have firsthand
knowledge from the interviewee regarding the case study (Lawrence & Tar, 2013). My
role included developing and planning the interview from interfacing with manufacturer
leadership and understanding their operations model. Their PLC and business model was
also included in my interviews. During the interviews, I ensured correct scheduling as
well as playing the role of interviewer by contacting their respective public information
officer (PIO) or administrative assistant in advance and providing pertinent information.
Throughout the data collection process, I focused on the fundamentals of the
research in uncovering answers to questions and collecting the evidence while producing
new findings not determined in past studies. I also considered marketing applications
after this study. The qualitative research was effective in ascertaining company’s core
values, business acumen, and awareness of market opportunities. However perspectives
on infusing an open business model in the organization were not received well by the
manufacturer, yet effective with the distributor network leaders and healthcare
professionals.
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As the researcher, I followed ethical procedures and protocol congruent with
Belmont’s Report. The Belmont Report published July 12, 1974, and based on the
National Research Act (Pub. L. 93-348), signed into law and creating the National
Commission for the Protection of Human Subjects of Biomedical and Behavioral
Research. The report drove changes to the Commission by identifying the basic ethical
principles and emphasizing their importance of conduct by biomedical and behavioral
research (Faden et al., 2013). The specified conduct and behavior was regarding human
subjects, and it included guidelines to assure research by these principles. Important and
prevalent situations include medical, nursing and caregiving settings (Sims, 2010) where
ethics in healthcare are especially necessary.
I remained objective during this research to ensure a scholarly approach to the
study of authentic interest, motivation, inquisitiveness, and commitment to uncovering
the data objectively. I secured objectivity by focusing on the business problem, adhering
to the research process, and retaining an outside-in perspective during interviews with
participants. The researcher has an integral role in the process and is the main instrument
of data collection (Bansal & Corley, 2011). The data collected from the research was
analyzed and compiled for independent interpretation. By following this plan, I ensure
the quality of research was conducted and free of bias and personal views.
The interview protocol is an important tool for mitigating bias and viewing data
without a personal influence. The interview protocol helps one retain an outside-in
perspective during interviews. I utilized an interview protocol as a tool to assist in
reducing biases. An interview protocol is a comprehensive instrument that researchers
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use to assist with data collection (Jacob & Furgerson, 2012). The protocol included
interview questions with procedural guidelines to assist participants in conducting the
interview from beginning to end. By following the interview protocol, I achieve
consistency across all interviews.
As the researcher, I focused on becoming knowledgeable of the facts during the
study. I remained cognizant of the importance and potential of infusing of new marketing
strategies and open business models for AED manufacturers and their distributors to
expand their customer base. As a part of the study, I plan to acknowledge potential
implications for positive social change. The implications include the potential to save the
lives and quality of life for over 350,000 SCA victims dying annually (AHA, 2013).
Other implications include reducing annual expense for U.S. consumers (Heidenreich et
al., 2011).
Participants
In this qualitative study, I chose a multicase study of the dominant leaders of
medical device manufacturers and have selected three PseudoAED, U.S., AED
distributors, and healthcare professional companies. I included six participants from the
manufacturers, distributors, and healthcare professionals. The participants represented
three important areas, which include marketing, sales, and product development from
their respective consumer goods division. The participants chosen were the most eligible
to discuss the infusion of new business models. As marketing professionals, they
influence any change in marketing strategies. By following the respondent selection
process, it assisted me in achieving triangulation by interviewing, assessing collected
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data, and exploring company’s website from multiple corporations and their perspectives
on the general and specific problem stated in this study.
Study participants, with the unique and specific ability to provide relative and
quality data, contributed answers to research questions during data collection (O’Reilly &
Parker, 2012). Their contribution assisted in reaching the point of data saturation
(Marshall, Cardon, Poddar, & Fontenot, 2013). Achieving saturation included data
review and new relevant information, perspectives, and experiences no longer appearing
from additional interviews (O’Reilly & Parker, 2012). Gaining access to these marketing
leaders was very difficult in part because some were still undergoing their PMAs while
others very leery of releasing sensitive marketing information that would end up with
their competitors. My initial approach was to use traditional and professional forms of
communication.
Other strategies included social media connections and professional organization
networking. However, they were not very effective. A last and final attempt was
leveraging their social responsibility for companies of this size as part of their operating
business and community outreach model. By identifying their community initiatives, it
reminded them of their company’s mission statement and thus helped me to connect and
began collaborating with senior leaders and other company employees. In contrast,
leaders from the distribution channels and healthcare professionals were very open and
receptive.
The initial interface established contact with potential participants and company
employees. After establishing contact, I remained mindful that they are employees of
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high responsibility and are decision makers in their respective companies. The selection
of these participants was an important and an integral component of the research process,
as well as remaining objective in their selection and maintained a perspective in
mitigating personal bias. In forming conclusions from the data collected from these
participants, there were no limitations in participant selection or influence to the quality
and outcome of the study (Reybold, Lammert, & Stribling, 2012).
The choice of the participants from multiple medical device manufacturers,
distributors, and healthcare corporations created a unique representation of senior-level
marketing, sales, and product development leaders responsible in some capacity for the
U.S. AED consumer market. The research questions previously prepared for the
interview were consistent with the protocol. The study included researching participants’
current and potential strategies for emerging markets. The purpose was to explore their
ability to contribute to the development of a new customer base in the AED marketplace.
By exploring their plans for expanding public, consumer, and private accessibility, there
is a likelihood a contribution to positive social change will arise. Most of the previous
studies, in this space of study, have not included the aging population entering retirement
as an emerging market or specific focus on in-home AEDs as a gap in market need or
demand.
The qualitative approach yields the criteria of objectives and personal
interactions, which were needed during information and data collection. The qualitative
information will consist of personal interviews, assessment of collected data, and
documents review to address the specific business problem. By probing and exploring the
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company’s perspective on open business models, it yields the necessary data for this
study. Exploring the company’s existing marketing strategies and plans with a medical
device manufacturing company and distributors’ leaders to expand their customer base
was an important objective.
Research Method and Design
An exploratory, multicase study design with the qualitative approach was the
most appropriate design for this study. I chose the qualitative method over quantitative
and mixed methods because of the personal nature of this approach (Ritchie, Lewis,
Nicholls, & Ormston, 2013). The qualitative research method was appropriate for this
study. The research method determined the planning and strategy point at which medical
manufacturing and distribution marketing leaders decide, or not, on AED products and
marketing strategies of their AED home units. The further determination to address
customer base expansion, based on current and emerging markets, was one of the results.
A case study was more appropriate for this research than phenomenology, narrative,
grounded theory, or ethnographic design. In-depth interviews were the most appropriate
for collecting data on naturally occurring behaviors in their usual contexts. In-depth
interviews were one method of data collection used in this study (Muskat, Blackman, &
Muskat, 2012).
My research approach involved exploring this case using more flexible and
interactive style of elicits questions categorized with each response for analysis. The
analytical objectives included their description and explanation of their relationship to
each interviewee and group norms where applicable. The study design was applied to the
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order of questions as well as additions, exclusions, or choice of particular questions
derived from my interviews, data collected, and company websites reviewed (Muskat et
al., 2012). In contrast, the selection of study design includes consistency in the approach
when developing interview questions, data collection, and analysis with the approach
taken (Lewis, 2015). Likewise, the consideration for a single-case versus a multicase
study was part of the planning as well as its design congruence (Barlow, Hersen, Barlow,
Nock, & Hersen, 2009). The information was then incorporated into the analysis and the
reflection phase of this study.
Method
Qualitative approaches to information gathering involve direct interaction with
individuals in a one-on-one or group setting. The purpose of the research was to find the
answers to important questions (Marshall, 2010). By researching, it provided me the
opportunity to understand experts’ perspectives of the AED U.S. market, target markets,
and awareness of emerging markets and product technologies. These qualitative data,
gathered through the interviews, help me to address the specific business problem
through a case study of multiple medical device manufacturers. The interviews included
open-ended questions aimed at uncovering what strategies and potential strategies
medical device manufacturing company marketing leaders, AED distribution channel
leaders, and healthcare professionals using to expand their AED customer base in the
consumer space. Interviews helped me to gather data to understand what strategies these
leaders are using and what potential strategies may develop.
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Research Design
The research design of this study was a case study. The case study was the most
appropriate for this study allowing for detailed exploration of more current information
within relevant subject matters while using multiple data collection and analysis
processes (Yin, 2013). Yin (2013) underscored the choice of selecting a multiple or a
multicase study for exploration as a choice for the researcher. I explored the strategies
marketing leaders from a medical device manufacturer are using to develop their
customer base, or not using, and emerging technologies in the AED consumer goods
market.
I used multiple sources of data collection such as semi-structured interview
questions and documentation thereby making the case study most suited for this research.
Both the qualitative study and its design method contributed to the resolution of the
business problem. Each question provided opportunities to describe the experiences and
perceptions of the medical device manufacturer marketing leaders, distributors, and
healthcare professionals on the topic of open business models (Chesbrough, 2012).
Reaching data saturation occurred after having leveraged the three types of data
collection to the point at which there was a diminishing return in collecting more data
(Marshall et al., 2013). These types include interviewing, assessing collected data, and
reviewing the companies’ website material. While collecting the data, I ensured there
were the necessary quantity and quality as part of reaching saturation.
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Population and Sampling
Population and Sampling
In choosing participants, I used a purposeful sampling approach. Participants of
choice were from marketing management as well as change agents with decision-making
responsibility and influence in their respective company. Participants of choice have
influence with company steering committees and vision-sharing in strategic direction.
This choice of sampling was in accord with Reybold et al. These authors depicted
purposive sampling as the strategy of achieving the best fit data to answer the research
question, making the best use of resources, and completing the study with resources
available (Reybold et al., 2012). In purposive sampling, the participants selected had
information that was relevant to the study (Petty, Thomson, & Stew, 2012).
A critical fundamental of creating credible research was obtaining an adequate
sample (Marshall et al., 2013). To reach data saturation with a minimum of six
participants by performing interviews with the respective participants, selecting a sample
size was contingent on the need to reach data saturation. Saturation is the point at which
diminishing returns in collecting more data exists (Marshall et al., 2013). Because the
number of participants in this study was sufficient, reaching saturation was foreseeable.
Their intellectual knowledge, decision-making responsibility, and access to resources
allocation included important information which added value to this study.
I conducted the interviews by telephone with the option of audio recording when
permissible. In the interview process, I targeted marketing leaders who were responsible
for the U.S. market in the consumer and distribution groups. These marketing leaders
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were from senior management ranks as well as change agents with decision-making
responsibility and influence in their respective company. The preferences in participants
were those who are responsible for strategic planning and marketing of the AED
consumer goods product line.
The participants interviewed were the most eligible interview candidates to
engage in my study and had the decision-making authority in infusing a new business
model and influence change in marketing strategies. In the regards to the medical device
and AED manufacturers operating in the United States, I formally approached (see
Appendix A as sample letter of cooperation) all three which included Pseudo AED U.S,
Pseudo2 AED U.S., and Pseudo3 AED U.S. I also approached Pseudo AED Distributor
U.S and Pseudo AED Distributor2 U.S because of their unique distribution models.
Because of their market presence and focus on health consumer products, the inclination
was towards Pseudo AED U.S. (Noel & Van Groningen, 2014). These manufacturers
engage in healthcare products and medical device manufacturing, specific to AEDs with
proprietary business models and research and development (R&D) groups. I found more
success with AED manufacturers distributors willing to share detailed information, to
some degree, than from medical device manufacturers. In contrast, both medical device
and AED manufacturers would not relate emerging market information in the consumer
space, nor were there any contingencies on the willingness of participants to share it. To
ensure all participants provide available data, I chose companies with public information
available.
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A point of saturation was achieved by performing interviews with a minimum of
six participants from their respective companies and area of responsibility, coupled with
sources of data from the company website and interviews. The point of achievement was
reached whereby there were no new information or topics, contributing to reaching a
point of saturation (Marshall et al., 2013). I conducted the interviews by way of
conference calls to ensure depth of research by checking in with all participants to
validate their responses.
Respecting participants’ time, I conducted telephone interviews with brevity and
efficiency, anticipating no longer than an hour in uninterrupted chambers. These
accommodations are important as they are leaders and an important stakeholder in the
company (Harvey, 2011). Jacob and Furgerson (2012) recommended that participants
conduct interviews in a quiet and private location. The purpose was to minimize
distractions, allowing for clear and audible communication, and to ensure data
confidentiality during data collection. I reviewed the protocol and consent form process
with participants to ensure compliance and sustainability throughout the fact-finding
process.
Ethical Research
Research ethics is the interaction between researchers and the participants they
study. The professional aspect of research ethics involves the issues of researchers’
interactions with participants. Research ethics includes intellectual property, mentoring
relationships, any potential fabrication of data, as well as plagiarism. As a researcher, I
was under the obligation to demonstrate trustworthiness and credibility as I execute the
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methodologies used in this research. This demonstration provided an ideal opportunity to
employ ethical literacy as I engaged in these contemporary methods (Jackson, 2013).
Because this study specifically involves human participants, I made certain to
include participants’ protection documents, consent forms, and a letter of cooperation.
Participants’ names and contact information are not recorded in the research records.
Participants’ names and information gathered from the interviews remain confidential.
Maintaining ethical conduct was imperative, especially while conducting research to
protect the rights of human participants. Once in receipt of approval from the
manufacturer, distributor, and healthcare professionals, I proceeded with the interviews
because I expected to eliminate any foreseeable conflict of interest. The research
procedures did not reveal criminal activity or child/elder abuse that necessitates reporting.
The research procedures did not reveal or create an acute psychological state that
necessitates referral.
Participants signed a consent form before the interview. I obtained Walden
University Institutional Review Board (IRB) approval for this study. The IRB approval
ensured the ethical protection of human subjects (see Appendix B). The words within the
consent form adhere to the U.S. Food and Drug Administration, Department of Human
Services and Walden University standards. At the time, I performed these interviews, I
followed the interview protocol (see Appendix C). I completed the National Institute of
Health Human Research Protection training (see Appendix D). As part of the protocol, I
provided each participant with a copy of the inform consent document. Securing
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signatures and scheduling a discussion with each participant was part of the interview
protocol.
I ensured there was ample time to answer any questions they had and explained
the purpose and reason for the study as well as their rights to withdraw. The importance
of reviewing procedure and protocol is to affirm and underscore the confidentiality and
voluntary process. The role of the IRB is to ensure research proposals are meeting the
criteria of applicable law for acceptability, institutional regulations, and professional
conducts and practices standards (Jackson, 2013). I actively anticipated and addressed
each ethical dilemma occurring at every phase of the research. I also respected vulnerable
populations and avoid putting participants at risk (DuBois et al., 2012). I did not
interview participants who may have been members of a vulnerable population. I
supported every decision with a scholarly peer-reviewed or a seminal source.
Last, I am maintaining the data in a safe place for 5 years after the date of the
published date to protect the confidentiality of participants. As part of compliance and
incentives, I will provide the senior management and participants a final copy of my
findings. I am protecting the names of individuals and organizations by pseudonyms, to
keep the participants and organizations confidential. This information is part of the
consent statement and nondisclosure agreement.
Data Collection
Instruments
In the data collection process, I ensured the study sustained a qualitative
interpretive research and the basic framework in collecting data and analyzed. The prior

66
research did not provide a framework for this study because it is in the public and
business sector and not in the consumer space. The lack of a framework created a need to
add to the research, seek new data, and instruments. The researcher is the main
instrument of data collection in qualitative research (Bansal & Corley, 2011) contributing
valuable information used for validation and proof.
I used open-ended questions to allow the participant to expand or emerge on the
subject matter or phenomenon in question. I used semistructured interviews with leaders
of the medical device manufacturer with questions regarding their marketing strategies
and emerging technologies to expand their consumer goods customer base. Congruent
with this approach, I sustained my role as the researcher by effectively interviewing each
participant gaining clarity and consistency with each question; assessing collected
organized and coded data, and reviewing the manufacturer’s web material for any
variance between data collected and data published. During the data collection process, I
validated the necessary quantity and quality in each area of research as part of reaching
saturation.
To gain profound experiences or views on a subject matter in this qualitative
study, I followed Silverman (2013), and relied on interviews to gain as much detail as
possible. In the initial permission letter to the medical device manufacturer, distributors,
and healthcare professionals, I requested permission to initiate contact to introduce
myself as the researcher and establish the premise of my study. Once the institutional
review board (IRB) approved my proposal, a letter of cooperation to the participating
companies followed, requesting permission to begin the interview process. The
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information about the instrument that I planned to use was conveyed, pertaining to
demographics and how it would remain congruent with other instruments used in
previous studies. I overcame the disadvantage of being on the participants’ premise faceto-face by utilizing telephone calls and audio recording capabilities when allowed
(Pickard, 2012).
As the researcher, I continuously uncovered any relevancy between the analysis
and data collection and data analysis guides in data collection (Buckle, Dwyer, &
Jackson, 2010). The three levels of analysis included the presentation of the data without
interpretation and abstraction. The second inclusion was a descriptive narrative using
field notes, interview transcripts, and researcher interpretations. The third inclusion was
building a theory based on interpretations and abstractions. Coding was a part of the data
collection process for data taken from field notes and interview transcripts. By coding the
data, I fractured the data and grouped it into codes for categorizing confluent events,
statements, and identifying the data (Holton, 2013). The research procedures and the
analysis/write-up plans were performed based on the data coding and not on the raw data
containing any participants’ identity. I develop a theory to explain what will happen to
the data. To determine what will happen to the data, a series of questions were used to
form the theory. They will be:
1. What phenomena do these data represent?
2. What category does a given incident indicate?
3. What is happening in the data, beyond the surface-level explanation?
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I, as the researcher, used open coding to determine the theoretical sensitivity, transcend
descriptive details, and encouraged a focus on patterns among incidents yielding codes.
I took several steps to ensure reliability and validity of data collected from the
interview process by quickly transcribing the interview recordings and ensured accurate
interpretation of the responses from participants (Yu, 2012). Upon completion of the
interview and the interpretation of their response, I allowed the participants to verify the
accuracy of the transcript through both telephone conversation and email allowing up to
10 days to review and return, as described in Seidman (2012). Participants reviewed their
respective transcripts and verified that the transcriptions were correct. There were no
discrepancies noted and secured an agreement with all participants ensuring that the
research accurately interpreted his/her intended response for each question.
Documentation was an important source of case study evidence from this research. I
conducted a review of any documents on the study topic such as reports or studies. I
retrieved information from the company’s website regarding AED products, services,
education & resources, specialties, marketing initiatives, financial posture, and
innovation paradigms. I also retrieved information from FDA websites related to
compliance and regulatory policies of AEDs, as well from a medical journal, and medical
organizations and other governmental websites to reach triangulation. The responses
across participants and corroborated data from the document review process were part of
facilitating the convergence of data (Yin, 2014).
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Data Collection Technique
The interview protocol included information, guidelines, and prompts to assist
with executing the interview from start to completion and to assist with maintaining
consistency across interviews (Jacob & Furgerson, 2012). I followed the procedures
outlined in the interview protocol to conduct the interviews. The interview script had an
introductory script. The script included the consent process which allows participants to
ask questions. Because I was aware of the AED manufacturers’ involvement of their
requirement to respond to the FDA’s PMA enforcement, there was an inclination with
these companies to conduct all interviews by telephone only. The purpose of the
interviews was to ensure accuracy and quality of each response to the research questions.
As the researcher, I made it my responsibility to secure and document the answers to the
questions and verbal responses. I used the following interview techniques to ensure the
interview process is effective in fully engaging participants. Jacob and Furgerson (2012)
recommended that researchers limit note taking during interviews so as not to distract
from maintaining eye contact with the participant. I requested permission to record
interviews to minimize the need to take notes.
Regarding the interviews, I requested from all participants to conduct the
interviews in a quiet location (Jacob & Furgerson, 2012) and thus, all resulted at their
business office. In making this request, it helped to eliminate distractions while ensuring
privacy and confidentiality of the data collected. Documented interviews and meetings
related to the topic provided an additional opportunity.
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Advantages associated with using interviews recordings, as a source of data
collection, was included as an option to participants when permissible by management
and participant. This option allows researchers to capture data not previously recorded
(Yin, 2014). The advantages also provided me an opportunity to listen to participants (see
Doody & Noona, 2013). Audio recordings allow the researcher to replay the interview to
capture details (Yin, 2014). Telephone interviews eliminated traveling and demands for
more time to reach participants as well as adding travel expenses. Six telephone
interviews were conducted each by telephone with no on-location interviews
In these remote access interviews by a telephone call, I secured prior approval
from participants to record the interviews as indicated in the consent form. Each
participant provided a signed consent form before his or her interview by email (see
Doody & Noona, 2013). If the participant did not provide approval to having the
interview recorded, I did not use audio recorders and only took notes.
Skype works over the Internet. My safety net for a possible weak connection was
to use other devices and telecommunication transports. This alternative was a good
prevention plan in avoiding disruptions to the interview process (see Hanna, 2012).
A poor interview was experienced with one of the AED distributors, however, it
was mostly due to an overcommitment of time by the marketing leader. Although
agreeing to participate in the interview, the focus was more on the existing PMA
response to the FDA at the headquarters, than on the interview. I concluded the interview
and both agreed on reconvening later. This resulted in a portrayal of mutual respect for
critical tasks and professionalism.
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Internet connectivity may vary depending on various components and services
because of telecommunications providers and equipment. Although Internet or
telecommunications connectivity never failed during the interviews, rescheduling was
always an option. Reviewing the manufacturer’s website material was part of the research
and assurance of the collection quantity and quality needed utilizing editing tools, notes,
written questionnaires, and saturation.
Data Organization Techniques
During my research, I requested permission from the participating companies to
record all conversations during the interviews using a digital voice recorder device.
However, because of their concern for security, in most cases, I was not permitted. My
plan, after each interview, was to have the recordings from my iPhone uploaded using
iCloud technology to download on my computer system in a password-protected
database. Additional steps of precaution included backup to the cloud provider for safe
keeping and identifying the recordings using labels to protect the identities of participants
(Fernando, Loke, & Rahayu, 2013). The systems used for keeping track of data included
a recording of teleconferencing; digital and hard copy transcribed notes; and answers to
the structured questions, as well as information from manufacturer’s website.
Regarding maintaining records and chronology, all documents such as schedules,
logs, journals, and labeling systems are being kept within the database. I secured all
consent forms containing participants’ interviews and any other research material in the
protection of any privacy risks. Maintaining data in a bank lockbox for a minimum of
five years after the date of the published date will be my protocol to ensure compliance
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and safekeeping for this study. After 5 years, the data will be destroyed by contracting a
security company to protect the privacy of consumer information and reduce the risk of
fraud and identity theft. I have taken appropriate measures to dispose of sensitive
information derived from participant interviews and any other information, through such
a company.
Data Analysis Technique
The data analysis technique included the review of the data without interpretation
and abstraction. A descriptive narrative using field notes, interview, transcripts, and
researcher interpretations was part of conducting an analysis of these interpretations and
abstractions. To analyze these data gathered for analysis from these in-depth interviews,
assessment of data collected, and company website, I used the modified van Kaam
method (Van Kaam, 1959). My objective was to identify the themes from a purposive
sample of a leading medical device manufacturer with approved consumer type AEDs by
the Federal and Drug Administration (FDA). I used various applications, such as MS
Word and Excel from the Microsoft Professional Suite software, to store the data
collected in this study. I chose this application compared to NVivo and Atlas.ti software
because of my familiarity with the use of the Microsoft Professional Suite and analytical
attributes. Each decision supported with scholarly peer review references.
Yin’s (2014) recommendation depicted the creation of a case study database in
data collection as one to store the information collected. I stored all field notes, data
collected from interviews, transcripts, and information from company official websites on
a password-protected database on my computer in which I have sole access. I maintained
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reliability and validity of the study (Yin, 2014) by rigorously following the protocol and
process set forth by this study. Using a tree format of folders, I organized each by the
participant with subfolders as supporting document to each interview as follows:
Folders
S 1-10
Sub-Folder
Inter1-6
Coding
X or O
Coding Levels
1-10 Positive or 0-(10) Negative
The database had a password protection feature and stored on the computer for 5
years. After 5 years, I will delete all raw data stored and collected from each of the files
with the case study database. I will destroy all printed documents in the bank lockbox by
shredding and discarding all documents using contracting a security company. As
stakeholders of the company, participants are eligible to receive written results of the
study. This is part of data organization and analysis protocol.
Confirmability and Replicability
Confirmability
In the quest to bring a unique perspective to this study, I confirmed and
corroborate with other subject matter experts in the field. I accurately measured a
qualitative study as past authors have enriched us with various potential concepts. I
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documented the procedures for detailed inspection and checking of the data throughout
the study. One method is confirmability defined by Petty, Thomson, and Stew (2012) as a
paradigm shift from such methods of measures as reliability. Reliability defined by
authors as Krefting (1991), focusing on the assessment of trustworthiness, confirmability
validates the assessment and the findings reflect the focus of the inquiry. Venkatesh,
Brown, and Bala, (2013) recommended the use of multiple sources to ensure reliability
when conducting qualitative studies as well as one mixing qualitative with quantitative
when considering participants and interview questions. Yin (2014) is consistent with
Venkatesh, Brown, and Bala, (2013) because using multiple sources of data such as
semistructured interviews and document reviewing also improves the reliability of a case
study. Poortman and Schildkamp (2012) expand on the use of a tool to document
systematic steps and procedures for data collection allowing consistency across
interviews thus making the research reliable. Poortman and Schildkamp defined
reliability as the measure of how replicable the research findings are independent of the
researcher and instrument.
By implementing recommendations from previous authors to achieve reliability,
various measures throughout the research process for this study and data collection did
take place. By allowing participants to review the analysis summary of the study results
based on my interpretation of the interview data (Yin, 2014) is further evidence of
achieving reliability. Yin suggested using multiple sources of data such as semistructured
interviews and document also reviewing improves the reliability of a case study. After
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completing the study, I conducted a data audit to examine my data collection and analysis
procedures and did not uncover any potential bias or distortion.
Replicability
Replicability, validity, and triangulation, per Golafshani (2003) as relevant
research concepts, must be redefined to reflect the multiple ways of establishing the truth.
Validity in research was this researcher’s goal to ensure it was, in fact, the conclusion or
derivative of the research reaching to the truth (Denzin & Giardina, 2012). Per Denzin
and Giardina, subdividing validity into four types addresses a specific methodological
question. I explored the methods and approach on how to investigate a research question
while seeking validity. I researched for data triangulation and secured it, which is a
technique that facilitates validation of data through cross verification from two or more
sources (Myers, 2013). The purpose for using triangulation was for additional means to
improve the credibility of the research findings. I achieved triangulation by interviewing,
assessing collected data, and exploring company’s website from the same corporation
regarding the general and specific problem stated in this study. As part of the qualitative
research for credibility, I described the participants’ understanding of the subject matter
to best describe it from their perspective. As in the interviews, I took the same approach
while extracting information from PseudoAED U.S. manufacturers’ websites, checking
each response, and the transcript review to validate and triangulate the data.
Transition and Summary
In Section 2, I described the methodologies and strategies that I used to approach
this study. The qualitative method of research, specifically a case design, has
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demonstrated to be the best method to approaching this study. I described how
conducting a qualitative research would yield the criteria of objectives and personal
interaction needed to information and data collection. This qualitative information,
through a multicase study with personal interviews, helped me to explore marketing
strategies and business models related to consumer AED market in the United States. By
exploring leaders perspectives in a leading medical device manufacturer, I uncovered
their motivation, or the lack thereof, toward an open business model to grow their
customer base.
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Section 3: Application to Professional Practice and Implications for Change
In Section 3, I present my findings alongside implications for professional
practice and social change. Section 3 includes my recommendation for reflections of all
phases of the study and further study. The qualitative method, specifically a case design,
was the method of approaching this study (Corbin & Strauss, 2014). Conducting
qualitative research provided an opportunity for personal interaction needed during
information and data collection. This qualitative information, through a multicase study
with personal interviews, helped me to explore marketing strategies. These strategies
included the relationship related to the consumer AED market in the United States. By
interviewing psuedoAED leaders of the consumer goods division, AED distribution
leaders, and healthcare professionals with the potential of motivating them toward an
open business model, leaders may develop strategies for growth strategies in their
customer base.
In this study, I addressed AED market potential in the United States. I explored
some medical device manufacturing and distribution marketing leaders’ marketing
strategies to determine whether they are maximizing their customer base growth or
leaving expansion opportunities in U.S. homes and public settings with unequipped AED
programs. Given the facts on the consumer AED void and SCA statistics, further research
of marketing strategies is recommended by this researcher. Further research is
recommended to also explore the probability of influencing some AED manufacturing
company leaders to recognize the value-add of an open business model, which stimulates
innovation that may contribute to the prevention of SCD. Last, I recommend that AED
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manufacturers and its distribution channels are made accountable in being responsive to
answering questions that address why current methods of the prevention of SCD continue
to fail.
Presentation of the Findings
In this section, I present the outcomes from the six interviews conducted. I
provided the results from each of the questions presented to the participants. Each
response is marked by an X for participants who responded to the respective question
(Taylor, Bogdan, & DeVault, 2015), with a +1 to +3 agreement level where +3 is greatest
agreement level and +1 being the lowest agreement level, as well as elaborated on the
topic accordingly as illustrated in Appendix E. Participants who chose not to respond or
disagreed with the question are marked 0 with a -1 to -3 disagreement level where -3 is
the greatest disagreement level and -1 is the lowest disagreement level, and elaborated on
the topic accordingly. I calculated an average score and noted it at the bottom of each
question. Interpretation of the findings for each question is noted at the bottom of each
table. A graph of the results for each question is provided to illustrate the results in visual
form (see Appendix E).
Interpretation of Findings
The themes that emerged from the data collected are strategies, and yield
professionals use while addressing the problem. The themes/strategies and supporting
data included: strategic marketing information security, dealing with regulatory
constraints, and commercial versus consumer focus.
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Strategy 1: Strategic Marketing Information Security
A common concern for the security of strategic marketing was evident across the
AED manufacturer participants with reluctance to discuss business models and marketing
plans. During the interview and data collection, senior marketing leaders expressed their
concerns regarding releasing any information. Strategic marketing information regarding
the consumer market was an area AED manufacturers did not directly lead or influence
and was left up to each individual distributor’s business model. Scores in Appendix E
illustrate low or negative O scores by AED manufacturer participants related to engaging
in partnerships; receptive to open business models; and the topic of sharing marketing
strategies with others in the industry. In contrast, participants from their distributor
network scored high or positive X scores in the same topic area.
Strategy 2: Dealing with Regulatory Constraints
The United States FDA has limited the number of approved AED manufacturers
making the available sample of participants limited. The U.S. market is one of the largest
in the world while AED manufacturers are mostly founded and originally established
overseas. Manufacturers, which are approved by the FDA, must comply with their
regulations and undergo frequent compliance reviews such as submitting premarket
approval applications (PMAs). These applications require AED manufacturers to undergo
a more rigorous review than what was required to market the medical devices in the past.
Per participants during the interviews, the FDA’s reasoning for PMAs is to strengthened
compliance reviews focused on the critical requirements needed to ensure the safety and
reliability of AEDs and their necessary accessories. However, the effect of exacerbated
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regulatory compliance, while important from a safety aspect, curtails AED manufacturers
limiting their innovation and marketing strategies. The potential of new products for the
consumer market in the distribution channels is directly correlated to federal and
regulatory sanctions.
Strategy 3: Commercial vs. Consumer Market Focus
Another common theme noted from AED manufacturer participants was their
delineation from the consumer as opposed to commercial product demands. During the
research, participants were not familiar with this shift in the healthcare industry and its
effects on the consumer or aging market. Consumer service and medical responsiveness
are considered by the AED manufacturers as an aftermarket outcome, however,
distributor partnerships and local community programs are effective. First responders and
hospital emergency units rely on trained CPR and AED bystanders. AED Manufacturers
have developed solutions in telemedicine but lack innovation in emerging markets being
developed by their partner network.
AED manufacturers do not sell directly to consumers and rely on their distributor
network for sales in this segment. This approach and perspective on the consumer market
were shared by all AED manufacturers. In addition, AED manufacturers’ close business
models and fear of IP loss curtail any opportunity for innovation in the consumer space.
AED distributors are more engaged with technology and innovative business
development opportunities to expand sales and market growth while servicing consumer
needs. Participants from healthcare services and systems providers of medicine agree that
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even though they do not control or influence AED pricing, they would participate as a
conduit to prescribing the need of an AED for a patient at risk for SCA.
Improving survival from SCA requires a system of care approach, and achieving
Guidelines-level treatment for OOHCA requires significant effort across multiple
healthcare segments. SCD prevention of healthy individual behaviors is not addressed in
this study. AEDs are for the prevention of Sudden Cardia Death and do not prevent
Sudden Cardiac Arrest. Participants from healthcare services and systems providers of
medicine agree that comorbidities in the CVD population and the baby boomer increase
in the elderly exceed sales growth of AEDs. Despite their agreement, sales in markets not
supplying the demand and need of having an AED quickly accessible in the homes and
public areas where the boomers spend their time, mortality statistics will continue to rise.
Participants from the manufacturing companies did not agree to comment in this
area in the protection of their competitive marketing strategy or unfavorable to expand on
their responses. Participants from distribution networks representing manufactured
products agreed to comment and favorable towards an open business model which
promoted innovation and new business opportunities. Participants from healthcare
services and systems providers concurred that affiliations and partnerships were
necessary when a knowledge, skillset, or resource is required and not possessed
internally, to fulfill their business mission statement.
AED manufacturers support current publications showing evidence that there are
limitations in having an AED at home. Affordability varies within the consumer market,
yet boomers of less financial resources, look to insurance companies for support.
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Consumers lack information and training in the use of an AED and thus uncertain in how
or when to use it if they decide to own a home unit. In the home, AED monitoring
solutions for prevention are emerging. Distributors are taking the initiative to create their
own marketing strategies and look to their respective manufacturers to develop products
that serve and accommodate the consumer market.
Participants from healthcare services and systems providers concurred that while
it may be 15 to 20 years from having an AED in every home, they also agree that it is
imperative for an AED to be readily accessible in every home. AED training and
informing potential bystanders in the home is an area healthcare service and systems
providers agree that it can be easily achieved. AED Bystander training programs lack in
the total solution for an effective response to SCA and preventing SCD. This issue is left
to First Responders and the distributor networks’ business model of value-add solutions.
Automated External Defibrillator distributors have adopted a new paradigm to address
this market gap. AED Bystander training programs lack in the total solution for an
effective response to SCA and preventing SCD. This issue is left to First Responders.
Few AED distributors have adopted a new paradigm for address this market gap
responders and the distributor networks’ business model of value add solutions.
Only one of the two participating U.S. AED manufacturer is involved and
approved to treat post-SCA patients using their medical devices and systems. The other
U.S. AED manufacturer not involved in medical devices and systems supporting postSCA hospital solutions was primarily because of technology development cost and
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stringent regulation by the FDA. Complete recovery for SCA victims includes post SCA
treatment by medical devices and systems.
Conclusions
The diversity in skill sets within the participants provided quality data from which
to draw objective conclusions. These participants represented the top three AED
manufacturers in the United States, North America, and the world. Participants shared
similar perspectives in their responses. When compared to the distributors representing
their respective AED product line, their perspectives differed in marketing strategies and
market growth potential. For example, some distributors are focused on direct sales by
way of the Internet and partnerships. Other distributors have non-profit mission
statements are engaged in the direct delivery of the end-user as well as AED bystander
training. When compared with the leaders in the medical community, their perspective on
the AED manufacturers and distributors widely differ and question their direction away
from the consumer demand and need.
The first conclusion with the AED manufacturer interviewees was their reluctance
to engage in an open business model discussion. Their lack or limited response regarding
this topic is primarily due to a business culture of protecting their intellectual property
(IP) and fear of their information getting to competitors. Other reasons included their
current compliance engagement from the U.S. Food and Drug Administration knows as
premarket approval application (PMA), which was set forth in 2015. The regulatory
challenge they face is FDA’s 2015 initiative (USFDA, 2015) for the approval of their
compliance stipulated for AEDs.
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The PMA initiative is concerned with the FDA’s issue of a final order requiring
AED manufacturers to submit premarket approval applications (PMAs). As participants
of this rigorous review, all AED manufacturers in the United States are cautious about
providing internal marketing strategies other than those published for public knowledge.
Whatever the underlining reason may have been, it was evident that each AED
manufacturer chose to limit the information and remain within their respective business
models. The participant interviews, alongside the use of the questionnaire, invoked
discussion as to why there are no concentrated strategies for the home AED unit where
most of SCA incidents are occurring.
Another conclusion is that AED manufacturers marketing strategies are more
focused on the commercial market and less on the consumer market, allowing their
market penetration onto the larger commercial accounts to influence smaller consumer
accounts. Their respective distributors have the autonomy to plan and execute on their
own marketing and sales strategies. If respective distributors adhere to and follow the
guidelines set forth in their distributors’ agreement, AED manufacturers allow them to
execute their individual marketing and sales plans. Since each distributor falls in a sales
volume tier, manufacturers concentrate their own sales in the commercial space.
A conclusion is that AED manufacturers have no significant focus on a home
AED solution and yet the one manufacturer of a home AED unit with FDA approval, in
this sample of participants, has established a consumer division along with a large tiered
distributor channel. However, other than their FDA-approved home AED unit for sale
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through distributors, their product line, and marketing is more concentrated on home
monitoring units for the elderly and home-bound markets.
Outcomes
Because the timing of the interviews, cooperating partners were involved in an
FDA initiative strengthening its review to help improve the quality and reliability of the
automated external defibrillator (USFDA, 2015). The outcome with AED manufacturers
included limited access to strategic marketing management as well as being receptive in
engaging themselves with this doctoral study. Time was limited and value-add to their
involvement was questioned, respectively. Outcomes of their marketing strategies
delineated from the consumer market, distributor network, and distributor network-only
models engaging partnerships in innovation.
Unlike the AED manufacturers, AED distributors focused on the consumer
market and were receptive to an open business model and partnerships. However, their
marketing strategies and sales channels are ubiquitous in nature. Larger for-profit
distributors’ sales are via the Internet, while some non-profit distributed provide AEDs at
no cost to the consumer, as well as a bystander and CPR training.
Leaders from the medical community engaged in various medical rendering
capacities in the field of CVD and SCD question the validity and purpose behind AED
manufacturers’ marketing and sales strategies. Moreover, they question their lack of
focus in markets where SCA occur the most and innovation would be best served. While
they do understand the scrutiny in which the FDA governs their end products, they
remain skeptical of the AED price tag per unit. Medical professional disagree with the
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cost of the AED products despite the regulatory challenges they face with FDA’s 2015
premarket approval application (PMA) initiative (USFDA, 2015). The PMA initiative has
to do with the FDA’s issue of a final order requiring AED manufacturers to submit
premarket approval applications (PMAs). The application forces AED manufacturers to
undergo a rigorous review. This review has far more rigor that has been required of the
AED manufacturers before marketing these devices in the past. The initiative itself is
questioned by the medical leaders of its real motive behind FDA’s rigor.
Outcomes of practicing a close business model were evident within the medical
device and AED manufacturers. None of the participants working for the leading U.S.
companies manufacturing AEDs were transparent in discussing their plans for product
development or emerging markets. Their partnerships did not include innovation or
integration to their existing product lines.
Outcomes from the interviews with participants representing AED distributor
channels did provide proof positive of engaging in partnership for product development
and innovation. This was specifically evident with distributors in for-profit business
models. However, many of the partnerships uncovered focused on further sales
distribution and community-based initiatives. Distribution and sales to sub-distributors
were identified, primarily in the retail arena among large pharmacy chain stores as well
as Internet sales. None of the sub-distributors were engaged in solutions involving CPR
or bystander training.
One large distributor and participant that was engaged as a non-profit company
providing AEDs in school sports for young adults, did have both an open business model
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and servicing its market with a total solution. The solution involved providing AEDs to
high school sports programs ensuring the safety of young athletes during sports events.
The athletic department included CPR and AED bystander training to all coaches and
administrative personnel.
Outcomes for consideration of further study regarding medical practitioners’
perspective on CVD, is a potential need. Participants from healthcare services and
systems providers of medicine agree that comorbidities in the CVD population and the
baby boomer increase in the elderly, and that they may be exceeding sales and growth of
AED markets. However, research in the study and current statistics continue to provide
proof that over 88% of all SCAs are occurring at home and other remote areas. Thus, the
assumptions stated before research are consistent with the finding. The question of CVD
outnumbering AEDs may be less valid than that of the number of AEDs lacking
marketing sales strategies in the market segments of need.
The data collected and its findings were part of the conceptual framework for
this study with the product life cycle (PLC) theory as a continuum. The four life stages
of a PLC in which a product passes through were evident during data collection from the
participants. The product introduction cycle, including development and design
compliance, was and continues to be an area of accountability which only the AED
manufacturer own. Product growth, from a development and marketing perspective, was
and continues to be a shared cycle of accountability by both the AED manufacturer and
their respective distributors. The maturity life cycle of the AED was evident from the
distributor participants, during the data collection, as distributors resell the product down
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in tiers as far as the retailer. The maturity of market, price, and technology. The AED
product decline, which distinctively shares more market characteristics with other
products in the same stage than with itself at a previous or later stage, occurs in the shelf
life of the distributors and retailers. As a vital life-saving product, having a maximum
shelf-life of five years, the AED declines in reliability and technology. During data
collection, it was noted that while the product declined over time, pricing was held by
each tier of the distributor.
As the AED product line was infused onto organizational marketing strategies,
PLC did provide useful insight into competitive tactics, an alternate perspective on how
to address issues of supply and demand. However, the variance in marketing strategies
from the manufacturer to the tiered distributors, yield different outcome to the respective
organizations. Since it is people which manage organizations, their influence and the
decision-making culture they created come from their behaviors. These decision-making
cultures and behaviors noted in the participants, during the interviews, influenced their
marketing strategies.
The problem-solving process for medical device manufacturers in the United
States was noted to have a dominant approach by its marketing leaders to PLC. However,
once the AED product was sold to master distributors and in turn master distributors to
sub-distributors, manufacturers lost their dominance with marketing strategies. This was
a pivotal and important finding during the exploratory and interview phase of the data
collection. As one manufacturing marketing leader stated, “we do not sell directly to our
consumer and only to our distributors. What they decide regarding marketing is their
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decision as long as they are compliant with the manufacturer-distributor agreement”. In
losing their dominance, manufacturers could not longer contribute to growing their
consumer customer base. In terms of the consumer market and its need to be supplied
with AEDs in critical segments, manufacturer marketing strategy dominance and
influence was lost.
Other findings and potential connection to the literature review from the data
collected were noted during the exploratory process. The first and foremost was the
connection of the data collected in contrast with the business marketing management
recommendations from scholars in this field. The delineation in marketing strategies
between the manufacturers and its distributors clearly showed disconnect and loss of
opportunities in the consumer space. In terms of the healthcare and retirement trends of
the aging boomer with the specific dependency of accessibility and immediate medical
attention in rural areas, the manufacturer did not entertain the topic nor were they concern
for these trends. While distributors to some extent are selling ubiquitously across markets
and servicing the boomer, they have no specific strategy towards the consumer segment
of the market. The same results were found in emerging technologies, safety, governance
and bystander training. During the data collection and interview process, one distributor
described the AED and its consumer market as “a commodity with little chance of being
purchased by homeowners, just look at all the publications.” Despite scholarly review
and widespread information on this topic along with the knowledge that 88% of SCAs
happen at home and public areas, data collected illustrates that there is no immediate
change in marketing strategies by AED manufacturers their respective distributors. The
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most receptive participants to the open business model and collaborative conversation
regarding innovative marketing strategies were the healthcare professionals.
In conclusion, while the PLC may augment open business models, manufacturers
are losing their dominance through both, PLC shortcomings, close business models, and
marketing strategies in the consumer space. Additional losses include the curtailment of
outside ideas and technologies to be infused and propagate onto their products and
services. This lack of infusion has reduced AED manufacturers’ their economic potential
(Chesbrough, 2012), curtailment in their business growth and social responsibilities.
Applications to Professional Practice
The purpose of this multicase study was to explore the marketing strategies
medical device manufacturing company leaders use to expand their consumer customer
base. The results were inconsistent with the initial purpose. However until initial contact
was made with the marketing manufacturers’ leaders, it would have been impossible to
uncover at an earlier stage. Medical device manufacturing company leaders were
reluctant to discuss their marketing strategies in detail and pivoted strategic marketing for
their consumer products to their distributor network. Their marketing strategies are to
focus on commercial products serving the demand of their larger customer base and
building their brand. Thus their strategy in label branding and product sales of medical
devices will proliferate onto their consumer product sales, such as the AED, through their
distributor network.
Making a shift towards the distributor network and healthcare professionals
accommodated the study since focus remained in the consumer space. Although the
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distributor network and healthcare entrepreneurs contributed to the study, it was also
evident their strategic solutions specific to the home AED unit sales included a different
strategic paradigm. Their paradigm included turnkey solutions for telemedicine;
emergency responds systems, as well as the prevention of sudden cardiac death.
Therefore, lobbying for regulation to expand their products to the home and public
segments of the market, which remain without an AED, should be a consideration for
action.
Based on peer-reviewed literature and SCD statistics from the AHA, distributors’
partnerships should include organization focused on solving for boomer demand and
healthcare solutions for the prevention of SCD by integrating their ideas and
technologies. Healthcare entrepreneurs should be a challenge in launching for-profit and
non-profit corporations with the mission to prevent SCD. These corporations would have
the required strategic vision, robust resource, and limited regulatory requirements to
invoke their solutions in the U.S. markets and beyond. The dissemination of these results
would ensure the aging population of boomers’ protection and prevention of SCD
worldwide. Also Based on participant’s comments from the AED manufacturer regarding
their marketing only on the commercial and not on the consumer market, it is clear that
marketing leaders need to re-think their marketing strategies.
The results of this study will be beneficial if these proposed applications for
business practice, in the consumer market space with an emphasis on the boomer, are
considered as critical objectives for more effective outcomes in regard to product
affordability; home AED target marketing; decrease in healthcare expense; and reduction
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of SCDs. In addition, by disseminating the findings and recommendations of this study
through publications and presentation of its results in professional conferences,
legislative session, and professional workshops, they will also yield effective outcomes.
The entire study will be published in the ProQuest/UMI dissertation database. As the
researcher, I also plan to publish parts of the study in several scholarly articles for other
aspiring entrepreneurs to further the study.
Implications for Social Change
As part of social change, the procurement and placement of AEDs may prevent
the loss of the lives to some of the 350,000 SCA victims dying annually of which 88%, or
more than 308,000, are occurring at home and public settings (AHA, 2013). This
qualitative case study and its design contributed toward a proposed solution for the
business problem. Residual outcomes included opportunities to make an additional
positive social change.
The outcomes derived from this research contributed to further motivate medical
device manufacturing and distribution marketing leaders to infuse positive changes.
Some changes may include influencing AED manufacturers, distributors, and medical
entities to adopt an open business model to further increase revenue in sales and service;
augment retail partners; infuse innovation in distribution channels, and gain a competitive
edge in the consumer goods space. Residual outcomes for social change may contribute
to improving the quality of life for the aging population while reducing the loss of the
lives of 350,000 SCA victims dying annually (AHA, 2013). In reducing the loss of lives,
it may help reduce costs of approximately $100 billion in annual expense (Heidenreich et
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al., 2011) for the United States alone. The purpose was to explore their ability to
contribute to the development of a new customer base in the AED marketplace. By
exploring their plans for expanding public, consumer, and private accessibility, an
expectation of remodeling their business remains as part of a contribution to social
change.
Previous studies in this space, such as Pruchno (2012) and Rashidi & Mihailidis
(2011), have not included the aging population entering retirement as an emerging
market. Although the foundation is established in which to develop marketing strategies,
no content is found on the topic. Yet, the large number of aging baby boomers retiring
and moving to remote areas without in-home AEDs is the greatest gaps in the consumer
market (Heidenreich et al., 2011). The literature review for this study premises other
issues and potential marketing opportunities that are part of this review. The inclusion is
specific to the dependency of accessibility and immediate medical attention and its
relation to AEDs with the knowledge that 88% of SCAs happen at home and public areas.
Solving for this dilemma would save the lives of the boomers; improve the changes of
quality of life for survivors, and reduce healthcare cost in the hundreds of millions of
dollars.
Recommendations for Action
Because of the findings stated in this study, I have several recommendations for
action. The recommendations are stated below in the order of priority. Each
recommendation includes specific and useful actions, as well as the identification of
those entities needing to act.
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Manufacturer marketing managers were the most difficult and least willing to
cooperate with this study. Their reluctance included concerns in disavowing critical
product and marketing information, which could be passed on to their competitors or
regulators. This mindset was also prevalent and noted during any discussion or questions
regarding the open business model. Their response pivoted to their distributor network as
the entity of choice for this topic.
Other reluctance to collaborate and give their time included a need for a returned
on investment for their contribution of information and time. Despite the fact, they work
in a highly-regulated sector with the medical device manufacturing community, resolving
serious product development and social issues, collaboration, and transparency will yield
a space of innovation and marketing opportunity. Thus, my recommendation is to
overcome AED manufacturers’ close business models by way of lobbying for regulation
to expand their products to the home and public segments of the market that remain
without an AED. The dissemination of these results would ensure the aging population of
boomers’ protection and prevention of SCD.
AED Distributor marketing managers were the most receptive to an open business
model and recipients of its value-add to their market growth. Distributors’ business
models varied with two distinct attributes and market focus. The first were those engaged
in commodity and retail sales with the available product online or on the shelf where the
market demand is filled by an as needed basis. This model has no proactive marketing
and advertising model reaching the aging and boomer population nor homeowner. It has
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no foundation for a proactive and preventive marketing strategy towards market growth
and prevention of SCD.
For this type of distributor, my recommendation is for them to invest in marketing
and advertising campaigns reaching the said market segment. In addition, I recommended
that their partnerships include organization focused on solving for boomer demand and
healthcare solutions for the prevention of SCD. The dissemination of these results would
ensure the aging population of boomers’ protection and prevention of SCD. The second
type of distributor is classified as an integrator.
The integrator-type distributor is one engaged with an innovative approach to a
complete solution. Their attributes include an open business model where both
technologies in product development and marketing strategy solve the business problem
and meet its social responsibility. While having both business model and attributes,
which yield an opportunity for solutions development for the home and public areas, their
focus is on the commercial segment of the market versus the consumer space. My
recommendation is to develop strategies to solve for these market growth opportunities
and move ahead of any potential future legislature mandating solutions by way of
compliance. The dissemination of these results and proactive marketing strategies would
ensure the aging population of boomers’ protection and prevention of SCD.
Healthcare professionals and the corporations they represented during the study
were the most engaged and partaking in solution development with the objective of
saving lives. Their approach to SCD included global ubiquity and problem solving for
each respective international market and inclusive of the aging population and its
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vulnerability of CVD. However, their limitations and ability to solve for the prevention of
SCD are contingent on the manufacturers and distributors of medical devices such as the
AED. Since this research has uncovered that healthcare professionals participating and
cooperating with this study have the financial resources and attributes of
entrepreneurship, my recommendation would be to challenge them in launching for-profit
and non-profit corporations with the mission to prevent SCD. These corporations would
have the required strategic vision, robust resources, and limited regulatory requirements
to invoke their solutions in the U.S. markets and beyond. The dissemination of these
results would ensure the aging population of boomers’ protection and prevention of SCD
worldwide.
Recommendations for Further Study
The uniqueness of this study is that I addressed a business problem by way of new
marketing strategies solving for market grown while directly contributing to a social issue
that remains to be solved. Despite having the tools and resources to combat SCD, the
United States is limited only by its entrepreneurial foresight and regulatory constraints.
Future studies could explore a close examination of the strategies needed in lobbying
regulatory entities to mandate for all new housing, existing homes, and public places to
have an AED unit installed.
Further research in new AED technologies that reduce the cost of AED home
units would contribute to the easing of access to a safe, reliable, and affordable product
for the aging boomer and general population. Other recommendations of further studies
include search-and-find mobile applications to locate AED positioning for immediate
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access, as well as bystanders training during SCA in public areas. A larger sample and
on-site interviews with medical device marketing managers would provide a greater
opportunity to discuss the infusion of open business models and strategic partnerships.
Future studies could include objectives towards social contribution in saving the lives of
the more than 340,000 annual cases of SCD (AHA 2013) outside healthcare facilities.
Inclusive in future studies, post-SCA medical equipment solutions to accelerate recovery
and minimize loss of productivity at the workplace is highly recommended.
As it relates to marketing strategies, further studies should have specificity in
researching how medical device manufacturers could pursue and compete in all AED
markets by adopting an open business model. Furthermore, that studies include
opportunities in establishing global presence while leading in technical reliability and
quality by leveraging redundancy, intelligence, and automation with the highest operating
standards possible. Lastly, the research should explore how an increase in profitability
and cash flow could be leveraged in providing product affordability for the aging baby
boomers.
Boomers will remain as the target market for medical devices such as the AED.
However, boomers are living longer and working past age 65 which creates an
opportunity for investments in products and services they will need upon retirement.
Further study of the boomer and investment opportunities in products and services they
will use or consume in the future are recommended. Boomers will continue to be an atrisk aging population with large healthcare facilities across remote and suburban areas
back to the metropolitan and inner city areas to minimize expenses. Further studies on
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how to solve the vast amount of healthcare services needed for the aging boomers retiring
in remote areas with less emergency response services and resources are recommended.
Reflections
I conducted this qualitative, multicase study to explore participants’ strategic
thinking, business model paradigm, and forward-thinking marketing strategies.
Moreover, I conducted the study to explore their experiences and perceptions on open
business models and seeking external expertise for innovation and social contribution.
The process exposed me to passionate and dynamic individuals dedicated to their mission
and the fundamental factors motivating them to sustain market growth. I was very
thankful for the exposure into this industry and impressed by the level of information
sharing by participating distributors and healthcare professionals. Their passion for
meeting the market demand and social needs epitomized a sincere accountability toward
the prevention of SCD.
As the researcher, I had preconceived ideas that the cooperating manufacturing
companies would be receptive the purpose of my research. However what I experienced
was a cautious and distant reception, filled with potential risk in conveying intellectual
property and marketing strategies. In the same way, I approached my cooperating
companies with an assumption that they would recognize the potential value in the
research process. The experience was a total antithesis and had to resort to leveraging
their accountability and social responsibility to this initiative.
In contrast, the experience was considerably different with participants from the
AED distribution network and healthcare professionals. They welcomed the value in
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partnerships and collaborative engagement as a way for business growth and combating
SCD. The effects of this researcher on the interface with participants throughout the
interviews yield changes in my perspective toward the problem-solving paradigm of the
study.
Summary and Study Conclusions
The study was conducted to solve a business problem. My initial perception was
that by influencing medical device manufacturer marketing managers to infuse an open
business model, the existing paradigm would be changed. The change was expected to
contribute towards new marketing strategies focused on the growth of the consumer
market. The true outcomes, after the research, were considerably different.
In this qualitative, multicase study, I used a questionnaire as the premise during
the interviews with the participants. Thus, it provided considerable insight to AED
manufacturer managers’ mindset and marketing perspectives towards the commercial and
consumer markets. The data collected, analyzed, and illustrated, supported the conclusion
that marketing manufacturer marketing strategies do not extend to the consumer market
as they are in the commercial market. Also, findings indicated that AED manufacturers
do not sell directly to the consumer nor are they involved with or influence the marketing
strategies for their distributors. Furthermore, findings supported the notion that their
reluctance to engaging in any such study outside their silo is indicative of their close
business model and protection of product knowledge and new developments. On the
other spectrum of this paradigm are the distributors and healthcare entrepreneurs
immersed in growth initiatives and emerging mhealth technologies. While neither have a
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specific focus on the total home unit solution or the baby boomer market, they practice an
open business model receptive to new ideas and partnerships.
Based on this study and previous research, I argue that a better business model,
regulatory emphasis, and social responsibility, are needed for a better model to improve
the reduction of sudden cardiac deaths. Therefore, this study demonstrates a need for
further investigations on other factors that may possibly affect the development of new
marketing strategies and regulatory mandates to improve AED performance, access, cost,
and search-and-find technologies to grow the AED consumer market.
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Appendix A: Cervantes Letter of Cooperation Request

SUBJECT: Request of Pseudo AED U.S., Inc. for Arturo Cervantes Doctoral Study
1. This letter is to request approval to interview six marketing and sales
professionals currently working for Pseudo AED U.S., Inc. as part of a doctoral
study. The Title of the study is Exploring Strategies for Expanding the U.S.
Automated External Defibrillator Market.
a. Mr. Cervantes’s doctoral study research design requires interviewing
marketing and sales managers to obtain firsthand experience and
knowledge related to marketing strategies medical device manufacturing
company leaders use to expand their U.S. consumer customer base.
b. Mr. Cervantes selected Pseudo AED U.S., Inc. because the company is
identified you as an industry leader in the United States and North
America. Interviewing members of Pseudo AED U.S., Inc. should enrich
the results of his research.
c. The questions of the interview do not intend to measure or evaluate the
practices, procedures, or operations of Pseudo AED U.S., Inc., its
subordinate organizations, its corporate offices or affiliates.
d. Granting permission to conduct the interviews is not an inference that
Pseudo AED U.S., Inc. is either endorsing or sponsoring this study.
Furthermore, Pseudo AED U.S., Inc. will not assume any liability for the
research under this study.
2. The Principal Researcher for this study is Mr. Arturo Cervantes.
a. Mr. Cervantes is a doctoral candidate in the school of Business and
Technology at Walden University.
b. Mr. Cervantes is the College President for Fortis College in Houston,
Texas.
c. Mr. Cervantes is currently working on a qualitative case study exploring
strategies for expanding the U.S. Automated External Defibrillator Market
with a social contribution in preventing sudden cardiac deaths (SCD) in
the United States.
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d. Mr. Cervantes’ doctoral study intent is to identify and collect the most
valued and relevant elements in the marketing, sales, and distribution of
the AED to the consumer market.
e. Dr. Michael Ewald, of the Walden University’s College of Management &
Technology DBA Program, will be the contributing faculty supervising
this research.
3. This is a request for cooperation to allow members of Pseudo AED U.S., Inc., to
engage in interviews to provide their perceived insight and knowledge.
a. The participation in this interview is voluntary. Participants meeting the
criteria and electing to participate in this interview not only will have the
option to decline to participate without penalty; they will have the option
to abandon the interview at any time during the interview process.
b. There will be no incentives or rewards offered for participating in the
interview.
c. Mr. Cervantes designed the questions to gather the knowledge and
experience of the participants on business performance and model, product
distribution, product affordability, strategies for expanding consumer
markets, and contribution to minimizing SCD.
d. All data collected will be from public operations and execution processes
related to the experience and knowledge of the participants.
e. The interview will entail ten open-ended questions related to strategies in
expanding the AED consumer market.
f. Mr. Cervantes request interviewing the participants as means of verifying
the responses to the interview questions.
g. To verify Mr. Cervantes’ interpretations of the interviews maintained the
integrity of their responses and his inferences accurately express the
participants’ opinions, Mr. Cervantes may schedule a follow-up memberchecking without any new questions with participants as a means of
verifying information and validity only if needed.
h. Mr. Cervantes will verify the accuracy of the transcript by allowing the
participant to have the opportunity to amend, modify, expand, or clarify
any of his or her original responses.
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4. Mr. Cervantes will protect the rights and welfare of Pseudo AED U.S. Inc., and
its participants by applying the following provisions.
a. Only Mr. Cervantes, and his doctoral committee (Dr. Michael Ewald, Dr.
Kelly Chermack, and Dr. Judith Blando), and authorized Walden
personnel will have access to the study’s data.
b. Mr. Cervantes will not use the participant responses outside the scope of
his research.
c. Mr. Cervantes will edit all responses to remove any information
describing specific information about Pseudo AED U.S., Inc., its
subordinate units, its higher command, or information readers can use to
identify the selected participants.
d. Mr. Cervantes will code all participants’ names, remove company name
from marketing documentation, and perform all data analysis and
conclusion based solely on this data code in order to protect the identity of
the participants.
e. Mr. Cervantes intends to conduct all interviews over the phone.
5. Mr. Cervantes does not have any influence or connections with Pseudo AED
U.S., Inc., or its employees eliminating potential conflict of interest concerns.
6. The point of contact is the undersigned.

Arturo Cervantes

___________

Arturo Cervantes, MBA
DBA Candidate
Technology Entrepreneurship
College of Management & Technology
Walden University
Email: arturo.cervantes@waldenu.edu
Mobile: (210) 569-4134

Pseudo AED Signee
Public Information Officer
Pseudo AED U.S., Inc.
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Appendix B: Interview Protocol and Questions
Interviewee Name: ___________________________________
Interview No: ______________

Date: _______________

Introduction:
Before we begin the interview, I would like to take this time to discuss and explain the
consent document before you. After explaining this document, I will be asking for your
signature to indicate that you are willing to participate in the study and this interview.
Thank you for agreeing to this interview. (Go through the informed consent of the
participant).
After obtaining signature:
As indicated in the inform consent document this interview will be recorded. (Start the
tape recorder).
Interview Questions
1. Would you describe how your company’s business model is open to
partnerships that promote innovation?
2. How does the U.S. automated defibrillator market compare to others in the
world?
3. How has your AED distributor network model evolved over the last few
years?
4. How far are we from having an AED in every home?
5. How will first responder services be affected in case of SCA with
hospitals moving from rural to metropolitan areas?
6. How is product affordability of AEDs for the aging senior consumer being
addressed by your company?
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7. Would you describe your company’s perspective of AED Training
Programs as a product value-add for market growth?
8. How have AED recalls influenced your product design?
9. Despite public awareness of CVD and large market share of AED sales in
the United States, why does CVD still account for over 340,000 deaths
outside of healthcare settings each year?
10. Would you elaborate on your company’s involvement in medical device
solutions for hospital treatment post-SCA?
Post Interview Comments:
Thank you for participating in this interview.
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Appendix C: National Institutes of Health Training Certificate
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Appendix D: Tables of Interpretation of Findings
Table D1
Strategies and Themes for S1
S1: How Open to Partnerships
Are very open and innovation-centric with the
potential to innovate yet protective of
intellectual property (IP)
Lead with industry’s technical knowledge by
exploiting external resources for knowledge
base
Need a paradigm change in capability to
transform the business for new growth
opportunities

Inter1m

Inter2m

Inter3d

Inter4d

Inter5h

Inter6h

0-3

O-2

X+3

X+2

X+1

X+1

0-3

0-2

X+3

X+3

X+1

X+2

0-3

0-2

X+3

0-1

X+1

0-1

Average Score
Interpretation of the findings:
• Interviewers from the manufacturing
companies did not agree to comment
in this area in protection of their
competitive marketing strategy or
unfavorable to expand on their
responses

-3

-2

+3

+2

+1

+1

•

Interviewers from distribution
networks representing manufactured
products agreed to comment and
favorable towards an open business
model which promoted innovation
and new business opportunities

•

Interviewers from healthcare services
and systems providers concurred that
affiliations and partnerships were
necessary when a knowledge, skillset,
or resource is required and not
possessed internally, to fulfill their
business mission statement
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Figure D1. S1 response chart.
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Table D2
Strategies and Themes for S2
S2: Defibrillator Market Comparison U.S. to
World
U.S. to World dominance – FDA approved
Europe and Latin America next largest with
growth potential
Asia and Pacific Realm smallest share with
slow growth and concerns with IP breaches
Average Score
Interpretation of findings:
• The United States FDA has limited
the number of approved AED
manufacturers
• The U.S. market is one of the largest
in the world while AED
manufacturers’ are mostly founded
and originally established overseas
• The next largest market opportunity
is with growth in Europe and Latin
America, with Asia and the Pacific
Realm following
• Manufacturers remain concern with
losing intellectual property (IP) in
entering the Asia and Pacific Realm
markets

Inter1m

Inter2m

Inter3d

Inter4d

Inter5h

Inter6h

X+3

X+2

X+1

X+1

0-1

X+2

X+2

X+3

X+1

X+1

0-1

X+3

X+1

X+1

0-1

0-1

0-1

X+1

+3

+3

+1

+1

-1

+3
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S2 Response
3.5
3
2.5
2
1.5
1
0.5
0

Figure D2. S2 response chart.
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Table D3
Strategies and Themes for S3
S3: Evolution of the Distributor Network
Model
Commercial networks traditionally have
included more corporate oversight with less
oversight on consumer distributors and remain
that way today
Traditional models applied to commercial
networks and retail via Internet distributions
are continuing to evolve within the distributor
networks
General community use and First Responder
use type products will remain with consumer
distributors; Clinical use type products with
corporate field sales force. No direct sales
from manufacturers to consumer markets are
expected in the future
Average Score
Interpretation of findings:
• The United States FDA has limited
the number of approved AED
manufacturers
• The U.S. market is one of the largest
in the world while AED
manufacturers are mostly founded
and originally established overseas
• The next largest market opportunity
is with growth in Europe and Latin
America, with Asia and the Pacific
Realm following
• Manufacturers remain concern with
losing intellectual property (IP) in
entering the Asia and Pacific Realm
markets
•

Product utilization by the consumer
reluctance remains in purchasing
decisions

Inter1m

Inter2m

Inter3d

Inter4d

Inter5h

Inter6h

O-3

O-3

O-3

X+3

O-2

O-1

O-1

O-3

O-3

X+3

O-2

O-2

X+2

X+3

O-3

X+3

X+2

X+1

-2

-3

-3

+3

-2

-2
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Figure D3. S3 response chart.
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Table D4
Themes and Strategies for S4
S4: AED in every home forecast
Consumer affordability and its use is volatile
Bystander reluctance of legal risks challenges
in home and public areas of AED utilization
Home technology innovations in monitoring
are emerging
Average Score
Interpretation of findings:
• AED manufacturers support current
publications showing evidence that
there are limitations in having an
AED at home
• Affordability varies within the
consumer market, yet boomers of less
financial resources, look to insurance
companies for support
• Consumers lack information and
training in the use of an AED and
thus uncertain in how or when to use
it if they decide to own a home unit
• In-home AED monitoring solutions
for prevention are emerging
•

Interviewers from healthcare services
and systems providers concurred that
while it may be 15 to 20 years from
having an AED in every home, they
also agree that it is imperative for an
AED to be readily accessible in every
home. AED training and informing
potential bystanders in the home is an
area healthcare service and systems
providers agree that it can be easily
achieved
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Figure D4. S4 response chart.
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Table D5
Strategies and Themes for S5
S5: Responder services effects on SCA
associated with hospitals rural-to-metropolitan
area transition
Consumer demands for product will be
serviced in accord with market shifts
First Responder services will continue to grow
and adapt to consumer demands
Home technology innovations in monitoring
will grow with this market shift as boomers
are located further from first-responder
services
Average Score
Interpretation of findings:
• AED manufacturers are not familiar
with this shift in the healthcare
industry and its effects on the
consumer or aging market
• Consumer service and medical
responsiveness is considered by the
AED manufacturers as an aftermarket
outcome, however, distributor
partnerships and local community
programs are effective
• First responders and hospital
emergency units rely on trained CPR
and AED bystanders
• AED Manufacturers have developed
solutions in telemedicine but lack
innovation in emerging markets being
developed by their partner network
•

Interviewers from healthcare services
and systems providers concurred that
the responders time will increase and
that later arrival times will decrease
the patient’s chances of survival from
SCA
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Figure 5D. S5 response chart.
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Table D6
Strategies and Themes for S6
S6: Product affordability of AEDs for the
aging senior consumer
Consumer market is indicating price is too
high and needs lowering trends
Innovation and new product releases will
influence lower pricing on existing models
with respect to all segments of the
consumer market
Partnerships from distribution channels are
adapting their business models to address
consumer needs
Average Score
Interpretation of findings:
• AED manufacturers do not sell
directly to consumers and rely on
their distributor network for sales
in this segment
• AED manufacturers’ close
business models and fear of IP loss
curtail any opportunity for
innovation in the consumer space
• AED distributors are more
engaged with technology and
innovative business development
opportunities to expand sales and
market growth while servicing
consumer needs
• Interviewers from healthcare
services and systems providers of
medicine agree that despite the
fact that they do not control or
influence AED pricing, they would
participate as a conduit to
prescribing the need of an AED for
a patient at risk for SCA
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Figure D6. S6 response chart.
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Table D7
Strategies and Themes for S7
S7: Describe your company’s perspective of
AED Training Programs as a product valueadd for market growth
AED training solutions as a value add for
AED manufacturer and its distributor network
Innovation and new product releases
contribute to the ease of AED use reluctance
Partnerships from distribution channels are
adapting their business models to address
consumer needs
Average Score
Interpretation of findings:
• AED Bystander training programs
lack in the total solution for an
effective response to SCA and
preventing SCD
• This issue is left to First Responders
and the distributor networks’
business model of value add solutions
• Few AED distributors have adopted a
new paradigm to address this market
gap
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Figure D7. S7 response chart.
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Table D8
Strategies and Themes for S8
S8: AED recalls influence on your product
design
AEDs sold in the U.S. must be Class III
approved
Products from 2012 to present have overcome
past deficiencies in being unable to deliver
needed defibrillator shock in a cardiac
emergency situation, yet the FDA remains
with rigorous enforcement of its policies and
oversight through PMA
Manufacturer’s self-initiate voluntary medical
device recalls of its AEDs to ensure reliability
and performance
Average Score
Interpretation of findings:
• AED Bystander training programs
lack in the total solution for an
effective response to SCA and
preventing SCD
• This issue is left to First Responders
and the distributor networks’
business model of value add solutions
• Few AED distributors have adopted a
new paradigm for address this market
gap
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Figure D8. S8 response chart.
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Table D9
Strategies and Themes for S9
S9: CVD still account for over 340,000 deaths
in the United States outside of healthcare
settings each year despite volume sales
Heart disease remains prevalent in this country
due to eating habits; lack of exercise; and
tobacco smoking
Sudden Cardiac Arrest is both result of poor
living behaviors and genetics
OOHCA Guidelines / System of Care
obstacles exist
Average Score
Interpretation of findings:
• Improving survival from SCA
requires a system of care approach,
and achieving Guidelines-level
treatment for OOHCA requires
significant effort across multiple
healthcare segments
• SCD prevention of healthy individual
behaviors are not addressed in this
study
• AEDs are for the prevention of
Sudden Cardia Death and do not
prevent Sudden Cardiac Arrest
• Interviewers from healthcare services
and systems providers of medicine
agree that comorbidities in the CVD
population and the baby boomer
increase in the elderly exceeds sales
and growth of AEDs
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Figure D9. S9 response chart.
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Table D10
Strategies and Themes for S10
S10: Role your company plays in medical
device solutions for hospital treatment postSCA
Ventricular fibrillation (a rapid quivering of
the main pumping chambers in the bottom of
the heart) called the ventricles occurring in
SCA, is treated by other medical devices postdefibrillation
Past heart attacks leave scar tissue that
changes the electrical patterns of the heart.
This risk factor is treated by other medical
devices manufactured by our company
Genetic disorders that cause subtle changes in
the heart rhythm are medical treatment and
surgically implanted versions for patients at
high risk
Average Score
Interpretation of findings:
• Only one U.S. AED manufacturer is
involved and approved to treat postSCA patients using their medical
devices and systems
• Less U.S. AED manufacturers are in
the medical devices and systems
supporting post-SCA hospital
solutions
• Complete recovery for SCA victims
includes post SCA treatment by
medical devices and systems

Inter1m

Inter2m

Inter3d

Inter4d

Inter5h

Inter6h

O-3

X+3

X+3

X+3

X+3

X+1

O-3

X+1

O-3

O-3

O-2

O-2

O-3

X+2

O-3

O-3

O-3

O-1

-3

+2

-3

-3

-2

-1

144

Figure D10. S10 response chart.

